Beyond TNF: TNF superfamily cytokines as targets for the treatment of rheumatic diseases

Key Points TNF inhibitors are among the most effective protein-based drugs for reducing inflammation associated with several rheumatic diseases In addition to TNF, the TNF superfamily (TNFSF) comprises other ligand–receptor combinations that might participate in the pathogenesis of rheumatic disease...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Nature reviews. Rheumatology Ročník 13; číslo 4; s. 217 - 233
Hlavní autori:	Croft, Michael, Siegel, Richard M.
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	London Nature Publishing Group UK 01.04.2017 Nature Publishing Group
Predmet:	4-1BB Ligand - antagonists & inhibitors 4-1BB Ligand - metabolism 692/4023/1670 692/420/256 692/420/2780 692/700/565/1436 Animals Antigens Arthritis Care and treatment CD27 Ligand - antagonists & inhibitors CD27 Ligand - metabolism CD40 Ligand - antagonists & inhibitors CD40 Ligand - metabolism Cell Death Cytokine TWEAK Cytokines Dendritic cells Dendritic Cells - immunology Development and progression Fas Ligand Protein - antagonists & inhibitors Fas Ligand Protein - metabolism Genetic aspects Growth factors Health aspects Humans Immune system Immune Tolerance Ligands Lupus Lymphocyte Activation Lymphotoxin-alpha - antagonists & inhibitors Lymphotoxin-alpha - metabolism Medicine & Public Health Molecular Targeted Therapy OX40 Ligand - antagonists & inhibitors OX40 Ligand - metabolism Proteins review-article Rheumatic diseases Rheumatic Diseases - drug therapy Rheumatic Diseases - immunology Rheumatology Signal Transduction T-Lymphocytes - immunology TNF-Related Apoptosis-Inducing Ligand - antagonists & inhibitors TNF-Related Apoptosis-Inducing Ligand - metabolism Tumor necrosis factor Tumor Necrosis Factor Ligand Superfamily Member 14 - antagonists & inhibitors Tumor Necrosis Factor Ligand Superfamily Member 14 - metabolism Tumor Necrosis Factor Ligand Superfamily Member 15 - antagonists & inhibitors Tumor Necrosis Factor Ligand Superfamily Member 15 - metabolism Tumor Necrosis Factors - antagonists & inhibitors Tumor Necrosis Factors - immunology Tumor Necrosis Factors - metabolism La Jolla California United States > US
ISSN:	1759-4790, 1759-4804
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Abstract	Key Points TNF inhibitors are among the most effective protein-based drugs for reducing inflammation associated with several rheumatic diseases In addition to TNF, the TNF superfamily (TNFSF) comprises other ligand–receptor combinations that might participate in the pathogenesis of rheumatic disease TNFSF members initiate several processes, including immune activation, tissue inflammatory responses and cell death or suppression Many TNFSF proteins other than TNF are being evaluated in preclinical mouse or human studies as possible therapeutic targets in rheumatic diseases TNFSF members can be targeted to either restore tolerance in rheumatic diseases or to regulate tissue cell responses In this Review, the authors discuss the function of the TNF and TNF receptor superfamily, their role in rheumatic diseases such as rheumatoid arthritis and systemic lupus erythematosus, and how current knowledge is being translated into potential disease therapies. TNF blockers are highly efficacious at dampening inflammation and reducing symptoms in rheumatic diseases such as rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis, and also in nonrheumatic syndromes such as inflammatory bowel disease. As TNF belongs to a superfamily of 19 structurally related proteins that have both proinflammatory and anti-inflammatory activity, reagents that disrupt the interaction between proinflammatory TNF family cytokines and their receptors, or agonize the anti-inflammatory receptors, are being considered for the treatment of rheumatic diseases. Biologic agents that block B cell activating factor (BAFF) and receptor activator of nuclear factor-κB ligand (RANKL) have been approved for the treatment of systemic lupus erythematosus and osteoporosis, respectively. In this Review, we focus on additional members of the TNF superfamily that could be relevant for the pathogenesis of rheumatic disease, including those that can strongly promote activity of immune cells or increase activity of tissue cells, as well as those that promote death pathways and might limit inflammation. We examine preclinical mouse and human data linking these molecules to the control of damage in the joints, muscle, bone or other tissues, and discuss their potential as targets for future therapy of rheumatic diseases.
AbstractList	TNF blockers are highly efficacious at dampening inflammation and reducing symptoms in rheumatic diseases such as rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis, and also in nonrheumatic syndromes such as inflammatory bowel disease. As TNF belongs to a superfamily of 19 structurally related proteins that have both proinflammatory and anti-inflammatory activity, reagents that disrupt the interaction between proinflammatory TNF family cytokines and their receptors, or agonize the anti-inflammatory receptors, are being considered for the treatment of rheumatic diseases. Biologic agents that block B cell activating factor (BAFF) and receptor activator of nuclear factor-κB ligand (RANKL) have been approved for the treatment of systemic lupus erythematosus and osteoporosis, respectively. In this Review, we focus on additional members of the TNF superfamily that could be relevant for the pathogenesis of rheumatic disease, including those that can strongly promote activity of immune cells or increase activity of tissue cells, as well as those that promote death pathways and might limit inflammation. We examine preclinical mouse and human data linking these molecules to the control of damage in the joints, muscle, bone or other tissues, and discuss their potential as targets for future therapy of rheumatic diseases. TNF blockers are highly efficacious at dampening inflammation and reducing symptoms in rheumatic diseases such as rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis, and also in nonrheumatic syndromes such as inflammatory bowel disease. As TNF belongs to a superfamily of 19 structurally related proteins that have both proinflammatory and anti-inflammatory activity, reagents that disrupt the interaction between proinflammatory TNF family cytokines and their receptors, or agonize the anti-inflammatory receptors, are being considered for the treatment of rheumatic diseases. Biologic agents that block B cell activating factor (BAFF) and receptor activator of nuclear factor-[kappa]B ligand (RANKL) have been approved for the treatment of systemic lupus erythematosus and osteoporosis, respectively. In this Review, we focus on additional members of the TNF superfamily that could be relevant for the pathogenesis of rheumatic disease, including those that can strongly promote activity of immune cells or increase activity of tissue cells, as well as those that promote death pathways and might limit inflammation. We examine preclinical mouse and human data linking these molecules to the control of damage in the joints, muscle, bone or other tissues, and discuss their potential as targets for future therapy of rheumatic diseases. Key Points TNF inhibitors are among the most effective protein-based drugs for reducing inflammation associated with several rheumatic diseases In addition to TNF, the TNF superfamily (TNFSF) comprises other ligand–receptor combinations that might participate in the pathogenesis of rheumatic disease TNFSF members initiate several processes, including immune activation, tissue inflammatory responses and cell death or suppression Many TNFSF proteins other than TNF are being evaluated in preclinical mouse or human studies as possible therapeutic targets in rheumatic diseases TNFSF members can be targeted to either restore tolerance in rheumatic diseases or to regulate tissue cell responses In this Review, the authors discuss the function of the TNF and TNF receptor superfamily, their role in rheumatic diseases such as rheumatoid arthritis and systemic lupus erythematosus, and how current knowledge is being translated into potential disease therapies. TNF blockers are highly efficacious at dampening inflammation and reducing symptoms in rheumatic diseases such as rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis, and also in nonrheumatic syndromes such as inflammatory bowel disease. As TNF belongs to a superfamily of 19 structurally related proteins that have both proinflammatory and anti-inflammatory activity, reagents that disrupt the interaction between proinflammatory TNF family cytokines and their receptors, or agonize the anti-inflammatory receptors, are being considered for the treatment of rheumatic diseases. Biologic agents that block B cell activating factor (BAFF) and receptor activator of nuclear factor-κB ligand (RANKL) have been approved for the treatment of systemic lupus erythematosus and osteoporosis, respectively. In this Review, we focus on additional members of the TNF superfamily that could be relevant for the pathogenesis of rheumatic disease, including those that can strongly promote activity of immune cells or increase activity of tissue cells, as well as those that promote death pathways and might limit inflammation. We examine preclinical mouse and human data linking these molecules to the control of damage in the joints, muscle, bone or other tissues, and discuss their potential as targets for future therapy of rheumatic diseases.
Audience	Academic
Author	Siegel, Richard M. Croft, Michael
AuthorAffiliation	2 Immunoregulation Section, Autoimmunity Branch, NIAMS, NIH, Bethesda, Maryland, USA 1 Division of Immune Regulation, La Jolla Institute for Allergy and Immunology, and Department of Medicine, University of California San Diego, La Jolla, California 92037, USA
AuthorAffiliation_xml	– name: 1 Division of Immune Regulation, La Jolla Institute for Allergy and Immunology, and Department of Medicine, University of California San Diego, La Jolla, California 92037, USA – name: 2 Immunoregulation Section, Autoimmunity Branch, NIAMS, NIH, Bethesda, Maryland, USA
Author_xml	– sequence: 1 givenname: Michael surname: Croft fullname: Croft, Michael email: mick@lji.org organization: Division of Immune Regulation, and Department of Medicine, La Jolla Institute for Allergy and Immunology, University of California San Diego – sequence: 2 givenname: Richard M. surname: Siegel fullname: Siegel, Richard M. email: siegelr@mail.nih.gov organization: Immunoregulation Section, Autoimmunity Branch, NIAMS, NIH
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/28275260$$D View this record in MEDLINE/PubMed
BookMark	eNp9ku2LFCEcxyUuuod63bsQgujN7qnjONqL4Dq6Co56c0HvxHF0x2tGN3WC_e9z2r1r96gQVPTz_T2fgiMfvAHgOUZLjCp-7mPszTQuCcLNkpBH4AQ3tVhQjujR3b0R6BicpnSLEKOMiyfgmHDS1IShE_DtndkE38Gbz1dv5g2maW2iVaMbNlBvcvjuvElQJZhVXJmcoA0R5t7AHI3Ko_EZBgt_R6Gy07Bzyahk0lPw2KohmWe78wx8vXp_c_lxcf3lw6fLi-uFZoTlhaqw0rxqq66ta93i1lZCNIxq1lorEFItZaqhiHWs0VVX41YrbTlSncbCEl2dgbdbu-upHU2nS0BRDXId3ajiRgbl5OGPd71chZ-yppxRhIuB1zsDMfyYTMpydEmbYVDehClJzEs4QnBMCvryAXobpuhLeoXilGBaE_GHWqnBSOdtKH71bFRezD6pYJwXavkXqqzOjE6XLltX3g8Er_YEvVFD7lMYpuyCT4fgi_2K3JfirukFON8COoaUorH3CEZyHiu5Gys5j5Ukc-L1A4V2Wc2eS9Bu-I8ObXWpePArE_cK9g_JL02L46Y
CitedBy_id	crossref_primary_10_1080_1744666X_2020_1685382 crossref_primary_10_1186_s12974_023_02912_9 crossref_primary_10_1016_j_autrev_2022_103210 crossref_primary_10_3389_fcell_2021_695533 crossref_primary_10_3390_microorganisms10071276 crossref_primary_10_3390_jcm14051460 crossref_primary_10_1016_j_ebiom_2017_07_023 crossref_primary_10_3390_pharmaceutics14010181 crossref_primary_10_1016_j_cmet_2020_06_013 crossref_primary_10_1016_j_kint_2020_07_007 crossref_primary_10_1016_j_psj_2020_07_045 crossref_primary_10_1146_annurev_immunol_082423_040557 crossref_primary_10_1038_s41418_017_0009_z crossref_primary_10_1186_s13075_020_02361_2 crossref_primary_10_1016_j_ijbiomac_2021_06_090 crossref_primary_10_1080_14712598_2022_2152321 crossref_primary_10_1038_s41573_019_0043_2 crossref_primary_10_1155_2019_3658215 crossref_primary_10_3390_life13020342 crossref_primary_10_1186_s12979_023_00379_z crossref_primary_10_1002_cbin_11230 crossref_primary_10_1016_j_envpol_2021_117671 crossref_primary_10_3390_ph15091080 crossref_primary_10_1007_s00125_020_05114_7 crossref_primary_10_3389_fimmu_2018_00640 crossref_primary_10_3389_fimmu_2021_694055 crossref_primary_10_1111_sji_12662 crossref_primary_10_3389_fimmu_2024_1466023 crossref_primary_10_3390_ijms18112296 crossref_primary_10_1111_cpr_13323 crossref_primary_10_3390_cells8080927 crossref_primary_10_4049_jimmunol_1900367 crossref_primary_10_3389_fimmu_2021_667357 crossref_primary_10_1002_jmv_28518 crossref_primary_10_1038_s41419_022_04759_z crossref_primary_10_1016_j_clnu_2022_05_007 crossref_primary_10_3389_fendo_2022_922501 crossref_primary_10_1007_s42764_019_00006_6 crossref_primary_10_1016_j_jaci_2025_04_034 crossref_primary_10_1038_s41392_023_01467_8 crossref_primary_10_3389_fimmu_2021_638020 crossref_primary_10_3389_fimmu_2022_824117 crossref_primary_10_1016_j_jaci_2017_11_024 crossref_primary_10_3390_epigenomes4030012 crossref_primary_10_3390_jcm12093271 crossref_primary_10_1186_s12891_025_08563_6 crossref_primary_10_1016_j_biopha_2022_112949 crossref_primary_10_3389_fgene_2022_1078790 crossref_primary_10_1038_nrrheum_2017_162 crossref_primary_10_4103_1673_5374_392854 crossref_primary_10_1128_spectrum_03172_22 crossref_primary_10_3389_fimmu_2024_1424259 crossref_primary_10_1111_imr_12706 crossref_primary_10_1016_j_imlet_2021_08_001 crossref_primary_10_3389_fcell_2023_1183163 crossref_primary_10_1016_j_talanta_2017_10_031 crossref_primary_10_3389_fimmu_2024_1338162 crossref_primary_10_1016_j_dci_2022_104374 crossref_primary_10_1038_s41419_022_04688_x crossref_primary_10_1186_s12891_024_07589_6 crossref_primary_10_1016_j_molmed_2018_05_004 crossref_primary_10_1016_j_dci_2022_104525 crossref_primary_10_1016_j_ymthe_2025_01_043 crossref_primary_10_1080_17512433_2017_1329009 crossref_primary_10_3892_etm_2021_10432 crossref_primary_10_1177_0961203318788153 crossref_primary_10_1016_j_biomaterials_2023_122247 crossref_primary_10_1007_s00011_021_01462_1 crossref_primary_10_1038_s41584_019_0307_6 crossref_primary_10_3389_fimmu_2025_1499663 crossref_primary_10_1016_j_jaut_2017_06_006 crossref_primary_10_1080_09546634_2019_1605143 crossref_primary_10_3389_fmicb_2022_926915 crossref_primary_10_1186_s12974_024_03208_2 crossref_primary_10_1155_mi_6005225 crossref_primary_10_1038_s41577_022_00792_3 crossref_primary_10_1038_s41573_020_0081_9 crossref_primary_10_3389_fimmu_2020_01766 crossref_primary_10_1016_j_cca_2018_06_028 crossref_primary_10_1038_s12276_021_00605_y crossref_primary_10_3389_fonc_2022_843880 crossref_primary_10_1111_ajt_15123 crossref_primary_10_3389_fimmu_2023_1285106 crossref_primary_10_1080_09273948_2019_1604974 crossref_primary_10_3389_fneur_2021_652867 crossref_primary_10_3389_fimmu_2022_818039 crossref_primary_10_1038_s41591_019_0415_5 crossref_primary_10_1038_s41467_021_21563_z crossref_primary_10_1126_scitranslmed_aar6584 crossref_primary_10_1016_j_intimp_2018_09_029 crossref_primary_10_3389_fimmu_2023_1095526 crossref_primary_10_1016_j_heliyon_2024_e25538 crossref_primary_10_1007_s00417_022_05600_1 crossref_primary_10_1016_j_berh_2021_101691 crossref_primary_10_1089_dna_2019_4631 crossref_primary_10_1007_s40744_021_00342_8 crossref_primary_10_1016_j_jaut_2025_103377 crossref_primary_10_1007_s10067_018_4209_9 crossref_primary_10_1002_biof_1806 crossref_primary_10_1038_s41584_021_00639_6 crossref_primary_10_1038_s41598_021_02167_5 crossref_primary_10_1038_s41573_024_01053_9 crossref_primary_10_1111_jre_12978 crossref_primary_10_1016_j_jpha_2025_101382 crossref_primary_10_1016_j_intimp_2020_107219 crossref_primary_10_1111_iji_70007 crossref_primary_10_1097_j_pain_0000000000001908 crossref_primary_10_3390_toxins11030178 crossref_primary_10_3390_scipharm91030036 crossref_primary_10_1016_j_canlet_2022_215661 crossref_primary_10_3748_wjg_v28_i19_0000 crossref_primary_10_1155_2022_1830431 crossref_primary_10_1007_s00018_021_03900_z crossref_primary_10_1155_2022_4337399 crossref_primary_10_1016_j_bioorg_2023_106766 crossref_primary_10_3389_fimmu_2018_00362 crossref_primary_10_3390_ijms21093263 crossref_primary_10_1136_annrheumdis_2019_215195 crossref_primary_10_3389_fimmu_2025_1563286 crossref_primary_10_1080_03009742_2023_2196781 crossref_primary_10_1016_j_jep_2024_118763 crossref_primary_10_1002_jcp_30089 crossref_primary_10_1111_jcmm_15737 crossref_primary_10_1186_s13287_020_01740_5 crossref_primary_10_1177_2042018820935771 crossref_primary_10_1016_j_ijpharm_2019_118625 crossref_primary_10_1111_jcmm_17470 crossref_primary_10_1038_s41574_022_00682_7 crossref_primary_10_1007_s12975_025_01349_x crossref_primary_10_1371_journal_pone_0223955 crossref_primary_10_1016_j_nutres_2019_05_006 crossref_primary_10_1016_j_jinf_2024_106231 crossref_primary_10_1155_2019_5107103 crossref_primary_10_1186_s13046_021_02019_0 crossref_primary_10_2217_imt_2019_0190 crossref_primary_10_3389_fimmu_2018_01354 crossref_primary_10_1016_j_clim_2022_109156 crossref_primary_10_1186_s13045_022_01325_0 crossref_primary_10_1111_imm_13620 crossref_primary_10_1134_S1990750821040028 crossref_primary_10_1038_s41419_019_1565_6 crossref_primary_10_1002_eji_201948393 crossref_primary_10_3389_fphar_2021_789080 crossref_primary_10_3390_ijms26125686 crossref_primary_10_1038_s41419_024_06506_y crossref_primary_10_3390_biomedicines10020264 crossref_primary_10_3389_fphar_2021_672515 crossref_primary_10_1146_annurev_immunol_042718_041447 crossref_primary_10_1002_adfm_202309447 crossref_primary_10_3389_fimmu_2021_796865 crossref_primary_10_1016_j_heliyon_2024_e24392 crossref_primary_10_1002_ctm2_369 crossref_primary_10_5114_reum_203129 crossref_primary_10_1038_s41584_019_0254_2 crossref_primary_10_1111_ced_13648 crossref_primary_10_3389_fimmu_2018_01658 crossref_primary_10_1038_s41467_020_14734_x crossref_primary_10_1111_1756_185X_14860 crossref_primary_10_3389_fcell_2021_737599 crossref_primary_10_3389_fphar_2022_924197 crossref_primary_10_3390_diagnostics14050529 crossref_primary_10_1007_s10238_019_00556_9 crossref_primary_10_1016_j_ajpath_2022_06_015 crossref_primary_10_3389_fimmu_2017_01584 crossref_primary_10_1016_j_cyto_2020_155391 crossref_primary_10_1016_j_cyto_2023_156446 crossref_primary_10_1155_2019_6804806 crossref_primary_10_1002_anie_202015129 crossref_primary_10_1093_rheumatology_key432 crossref_primary_10_3389_fgene_2023_1083615 crossref_primary_10_1096_fj_202002128RR crossref_primary_10_3389_fped_2022_872152 crossref_primary_10_1177_0961203319829818 crossref_primary_10_3389_fimmu_2023_1156212 crossref_primary_10_1016_j_intimp_2017_09_029 crossref_primary_10_1016_j_semarthrit_2020_03_013 crossref_primary_10_1016_j_cca_2018_03_010 crossref_primary_10_1007_s00223_019_00542_z crossref_primary_10_3389_fphar_2019_01530 crossref_primary_10_1038_s41584_018_0042_4 crossref_primary_10_1002_ange_202015129 crossref_primary_10_1016_j_intimp_2023_110453 crossref_primary_10_1038_s41467_022_33006_4 crossref_primary_10_1038_s41467_021_25710_4 crossref_primary_10_1016_j_jacig_2025_100483 crossref_primary_10_1038_s41590_023_01588_w crossref_primary_10_3748_wjg_v28_i19_2088 crossref_primary_10_3389_fonc_2019_00600 crossref_primary_10_3389_fimmu_2019_00204 crossref_primary_10_3389_fgene_2021_630310 crossref_primary_10_1038_s41413_025_00448_7 crossref_primary_10_3389_fimmu_2020_588776 crossref_primary_10_3389_fimmu_2021_712632
Cites_doi	10.1007/978-3-642-45106-5_19 10.1189/jlb.0910528 10.4049/jimmunol.0901637 10.1038/jid.2015.124 10.4049/jimmunol.0901112 10.1016/j.cyto.2015.07.014 10.1517/14712598.2015.973398 10.1172/JCI81217 10.1111/j.1365-2249.2006.03141.x 10.1681/ASN.2014030233 10.1016/j.ajpath.2012.01.003 10.1371/journal.pone.0112545 10.1038/sj.cdd.4401186 10.1038/ni894 10.1111/j.1365-2249.2007.03363.x 10.1038/nm1107 10.1038/nrrheum.2016.145 10.1186/ar1722 10.1186/ar2816 10.1186/s12863-015-0279-8 10.1136/ard.2008.090548 10.1182/blood-2009-08-239145 10.1038/356314a0 10.1002/(SICI)1521-4141(199801)28:01<290::AID-IMMU290>3.0.CO;2-S 10.1172/JCI200317662 10.4049/jimmunol.1303239 10.1016/S0968-0004(01)01995-8 10.1038/ng.233 10.1007/978-1-4419-6612-4_39 10.1007/s10238-012-0226-1 10.4049/jimmunol.178.11.7325 10.1016/j.cyto.2008.12.001 10.1136/ard.2009.109579 10.1016/j.smim.2014.02.006 10.1097/TP.0b013e318264d3ef 10.1002/1521-4141(200010)30:10<2815::AID-IMMU2815>3.0.CO;2-# 10.1136/ard.2006.055111 10.1038/nrd3930 10.3899/jrheum.080120 10.1074/jbc.272.51.32401 10.1189/jlb.0505238 10.1073/pnas.1321071111 10.1038/jid.2015.110 10.1093/rheumatology/kes339 10.1016/j.ajpath.2011.11.018 10.1038/316552a0 10.1016/j.cytogfr.2004.03.011 10.1038/gene.2010.44 10.1093/rheumatology/ken006 10.1111/j.1476-5381.2011.01753.x 10.4049/jimmunol.1103354 10.1038/sj.cdd.4401187 10.1038/nature03337 10.1016/j.clim.2008.07.014 10.1136/annrheumdis-2013-203991 10.1146/annurev-immunol-030409-101243 10.4049/jimmunol.181.9.5912 10.1016/j.jaci.2014.12.1936 10.1186/ar2617 10.1080/03009740801898608 10.1172/JCI20742 10.1002/eji.201445388 10.1186/s13075-014-0467-3 10.1093/rheumatology/kem063 10.1007/s00403-014-1497-z 10.1016/S0092-8674(03)00521-X 10.1016/j.autrev.2011.05.001 10.1038/sj.gene.6364097 10.3109/03009742.2013.848931 10.3899/jrheum.120886 10.1093/rheumatology/keu171 10.1016/j.smim.2014.02.005 10.1007/978-1-4419-6612-4_29 10.1002/art.24721 10.1016/j.molimm.2007.05.013 10.4049/jimmunol.179.11.7949 10.1016/0092-8674(95)90013-6 10.4049/jimmunol.1202659 10.1016/j.immuni.2007.05.004 10.1186/ar1867 10.4049/jimmunol.177.4.2610 10.1093/intimm/dxh162 10.4049/jimmunol.171.6.2930 10.3109/08916930109001958 10.4049/jimmunol.171.1.115 10.1517/17425255.2015.1000860 10.1038/nature11242 10.1038/cdd.2009.114 10.1016/j.jdermsci.2010.06.011 10.1111/j.1524-475X.2012.00785.x 10.1002/art.38770 10.1016/j.phrs.2015.12.018 10.1172/JCI42933 10.1002/art.30613 10.1016/j.smim.2009.05.012 10.1038/nm1202-796 10.1111/j.1600-065X.2008.00633.x 10.1371/journal.pgen.1000528 10.1016/j.pharep.2014.05.004 10.1006/clin.1996.0184 10.1111/j.1600-0625.2011.01304.x 10.1006/clin.1996.0106 10.1189/jlb.3RI0315-095R 10.1093/rheumatology/ker345 10.1186/ar2607 10.1038/nrrheum.2013.136 10.4049/jimmunol.176.3.1889 10.1186/s13073-016-0329-5 10.1084/jem.20072528 10.1016/S0923-2494(94)80189-4 10.1172/JCI200319209 10.1002/eji.201142162 10.1016/j.joca.2014.10.003 10.1126/science.7689748 10.1111/j.1365-2567.2007.02653.x 10.1016/j.immuni.2008.04.021 10.1002/art.38755 10.1186/s13075-014-0474-4 10.1136/ard.2008.096495 10.1016/S0092-8674(01)00237-9 10.4103/0256-4947.75775 10.1111/j.1600-065X.2011.01054.x 10.1038/nrneph.2015.206 10.1016/j.jaut.2013.03.002 10.1038/mi.2014.37 10.1038/cdd.2010.155 10.1517/14728222.2014.888415 10.1016/j.molimm.2012.01.007 10.1016/S1074-7613(01)00232-1 10.4049/jimmunol.179.4.2609 10.1016/j.bbadis.2013.05.032 10.1038/364806a0 10.1007/978-0-387-89520-8_2 10.1126/science.7539157 10.1177/0961203315583543 10.1016/j.jaut.2011.10.001 10.4049/jimmunol.175.2.1295 10.1146/annurev.immunol.23.021704.115839 10.4049/jimmunol.1501877 10.3109/03009742.2012.727026 10.1074/jbc.274.46.33166 10.1038/nri1148 10.1111/j.1749-6632.2003.tb06052.x 10.1002/eji.200535421 10.1007/978-0-387-89520-8_10 10.1016/j.clim.2012.01.005 10.4049/jimmunol.1301475 10.1038/ng.2007.47 10.1136/ard.2009.116434 10.1681/ASN.2007060706 10.1186/ar2941 10.1016/j.ajpath.2013.05.027 10.1126/science.7679801 10.1186/ar3294 10.1155/2012/265868 10.4049/jimmunol.169.8.4628 10.1016/S0041-1345(98)01365-7 10.4049/jimmunol.171.2.1061 10.1002/eji.200636872 10.1056/NEJM199611283352204 10.3899/jrheum.081312 10.4049/jimmunol.177.9.6433 10.1038/nri2526 10.1007/s00296-011-2002-z 10.1186/ar3100 10.1016/j.clim.2012.08.008 10.1093/intimm/dxu102 10.1007/s00296-015-3277-2 10.1681/ASN.V1181426 10.1016/j.cellimm.2014.07.004 10.1002/eji.200324088 10.1038/emm.2004.2 10.1186/s13075-015-0757-4 10.1016/j.cyto.2010.12.003 10.1111/j.1600-065X.2011.01068.x 10.1016/S0002-9440(10)63670-X 10.1111/j.1600-065X.2009.00774.x 10.1002/art.21821 10.1002/art.38806 10.1016/j.it.2011.10.004 10.1038/nri1151 10.1016/j.cyto.2014.12.026 10.1155/2010/239083 10.1002/art.20221 10.1124/jpet.109.159517 10.4049/jimmunol.0802645 10.1002/art.10856 10.1111/j.1600-065X.2008.00755.x 10.1038/nrd3436 10.1093/ndt/gfn461 10.1038/ki.2015.280 10.1016/S0092-8674(00)80605-4 10.1111/j.1365-2567.2004.01952.x 10.1002/art.10681 10.1016/j.clinthera.2013.06.008 10.1002/eji.201141659 10.1681/ASN.2007050577 10.1016/j.immuni.2015.05.012 10.4049/jimmunol.1500356 10.1111/ajt.13377 10.1002/eji.200839057 10.1136/annrheumdis-2011-150573 10.1084/jem.20071364 10.1111/j.1600-065X.1996.tb00921.x 10.1111/j.1600-065X.2011.01063.x 10.1038/nrrheum.2015.169 10.1111/j.1399-3038.2010.01111.x 10.1084/jem.20072378 10.3389/fimmu.2014.00511 10.1371/journal.pone.0157105 10.3389/fimmu.2014.00050 10.1007/BF02208342 10.1038/nrrheum.2014.33 10.1136/ard.2003.006148 10.1159/000371845 10.1016/j.clim.2013.03.002 10.1002/art.20255 10.1155/2013/340751 10.1096/fj.04-3556com 10.4049/jimmunol.157.7.3159 10.4049/jimmunol.154.3.1470 10.1002/art.39943 10.4049/jimmunol.156.9.3133
ContentType	Journal Article
Copyright	Springer Nature Limited 2017 COPYRIGHT 2017 Nature Publishing Group Copyright Nature Publishing Group Apr 2017
Copyright_xml	– notice: Springer Nature Limited 2017 – notice: COPYRIGHT 2017 Nature Publishing Group – notice: Copyright Nature Publishing Group Apr 2017
DBID	AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M7P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 5PM
DOI	10.1038/nrrheum.2017.22
DatabaseName	CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection (ProQuest) ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC Biological Science Collection ProQuest Central Natural Science Collection ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Collection (ProQuest) ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection Health & Medical Collection (Alumni) Medical Database ProQuest Biological Science Database (ProQuest) ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles)
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	ProQuest Central Student MEDLINE MEDLINE - Academic
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1759-4804
EndPage	233
ExternalDocumentID	PMC5486401 4321448615 A486449688 28275260 10_1038_nrrheum_2017_22
Genre	Journal Article Review
GeographicLocations	La Jolla California United States--US
GeographicLocations_xml	– name: La Jolla California – name: United States--US
GrantInformation_xml	– fundername: NIAID NIH HHS grantid: R01 AI103021 – fundername: NIAID NIH HHS grantid: U19 AI070535 – fundername: NIAID NIH HHS grantid: R21 AI123134 – fundername: NIAID NIH HHS grantid: R03 AI110929
GroupedDBID	--- .XZ 0R~ 29M 39C 3V. 53G 70F 7X7 88E 8FE 8FH 8FI 8FJ AAEEF AARCD AAWTL AAWYQ AAYZH AAZLF ABAWZ ABJNI ABLJU ABUWG ACGFS ADBBV AENEX AFFVI AFKRA AFSHS AGAYW AGHTU AHBCP AHMBA AHOSX AHSBF AIBTJ ALFFA ALMA_UNASSIGNED_HOLDINGS ARMCB AXYYD BBNVY BENPR BHPHI BKKNO BPHCQ BVXVI CCPQU DB5 EBS EE. EJD EXGXG F5P FQGFK FSGXE FYUFA HCIFZ HMCUK HZ~ IAO IHR IHW INH INR ITC LK8 M1P M7P NNMJJ ODYON OVD PQQKQ PROAC PSQYO RNR RNT RNTTT S70 SHXYY SIXXV SNYQT SOJ TAOOD TBHMF TDRGL TEORI TSG UKHRP AAYXX AFANA AFFHD AGSTI ALPWD ATHPR CITATION PHGZM PHGZT PJZUB PPXIY PQGLB ABFSG ACSTC AEZWR AFHIU AHWEU AIXLP CGR CUY CVF ECM EIF NFIDA NPM 7XB 8FK AZQEC DWQXO GNUQQ K9. PKEHL PQEST PQUKI PRINS 7X8 PUEGO 5PM
ID	FETCH-LOGICAL-c626t-a31ac83b3db55cb1bf399764c6bff900ab46a7406d67c3d51bcacf80adc19f2c3
IEDL.DBID	M7P
ISICitedReferencesCount	225
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000397312400005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1759-4790
IngestDate	Tue Nov 04 01:37:27 EST 2025 Thu Sep 04 16:45:30 EDT 2025 Tue Oct 07 06:52:14 EDT 2025 Tue Nov 11 10:36:24 EST 2025 Tue Nov 04 18:07:04 EST 2025 Thu May 22 21:13:41 EDT 2025 Mon Jul 21 06:05:24 EDT 2025 Tue Nov 18 21:00:17 EST 2025 Sat Nov 29 06:40:37 EST 2025 Fri Feb 21 02:39:52 EST 2025
IsDoiOpenAccess	false
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	4
Language	English
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c626t-a31ac83b3db55cb1bf399764c6bff900ab46a7406d67c3d51bcacf80adc19f2c3
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-3 content type line 23 ObjectType-Review-1
OpenAccessLink	http://doi.org/10.1038/nrrheum.2017.22
PMID	28275260
PQID	1884214529
PQPubID	2041929
PageCount	17
ParticipantIDs	pubmedcentral_primary_oai_pubmedcentral_nih_gov_5486401 proquest_miscellaneous_1876499812 proquest_journals_1884214529 gale_infotracmisc_A486449688 gale_infotracacademiconefile_A486449688 gale_healthsolutions_A486449688 pubmed_primary_28275260 crossref_primary_10_1038_nrrheum_2017_22 crossref_citationtrail_10_1038_nrrheum_2017_22 springer_journals_10_1038_nrrheum_2017_22
PublicationCentury	2000
PublicationDate	2017-04-01
PublicationDateYYYYMMDD	2017-04-01
PublicationDate_xml	– month: 04 year: 2017 text: 2017-04-01 day: 01
PublicationDecade	2010
PublicationPlace	London
PublicationPlace_xml	– name: London – name: United States
PublicationTitle	Nature reviews. Rheumatology
PublicationTitleAbbrev	Nat Rev Rheumatol
PublicationTitleAlternate	Nat Rev Rheumatol
PublicationYear	2017
Publisher	Nature Publishing Group UK Nature Publishing Group
Publisher_xml	– name: Nature Publishing Group UK – name: Nature Publishing Group
References	Kalunian (CR47) 2002; 46 Horai (CR57) 2004; 114 Gan (CR106) 2013; 2013 Citores (CR37) 2004; 63 Furie (CR206) 2011; 63 Tak (CR109) 1996; 80 Boot (CR59) 2005; 7 Laustsen (CR69) 2014; 16 Lee, Yang, Li, Weyand, Goronzy (CR110) 2007; 179 Zhang (CR82) 2009; 183 Al-Lamki (CR96) 2008; 19 Ferrant (CR48) 2004; 16 Croft (CR4) 2003; 3 Anders, Jayne, Rovin (CR214) 2016; 12 Aringer, Smolen (CR217) 2012; 11 Gattorno (CR112) 2002; 20 Shih (CR79) 2011; 691 Meylan, Richard, Siegel (CR77) 2011; 244 Pundt (CR189) 2009; 11 Xiu, Shen, Tian, Xia, Lu (CR86) 2015; 72 Nowakowska, Kissler (CR229) 2016; 196 Karin, Gallagher (CR25) 2009; 228 Silke, Brink (CR24) 2010; 17 Ruby (CR226) 2009; 183 Stohl (CR218) 2013; 9 Caso, Costa, Del Puente, Scarpa (CR12) 2015; 15 Peters, Stunz, Bishop (CR28) 2009; 21 Browning (CR131) 2008; 223 Croft (CR210) 2014; 26 Lee, Bae, Choi, Ji, Song (CR44) 2015; 24 Ware (CR132) 2009; 647 Klebanoff (CR201) 2016; 126 Giacomelli (CR58) 2001; 19 Weinblatt (CR216) 2007; 66 Feldman, Taylor, Paleolog, Brennan, Maini (CR2) 1998; 30 Murata (CR68) 2002; 169 Beutler (CR1) 1985; 316 Soforo (CR219) 2010; 37 Croft, Benedict, Ware (CR11) 2013; 12 Kamijo (CR160) 2008; 47 Ucero (CR162) 2013; 1832 Blotta, Marshall, DeKruyff, Umetsu (CR33) 1996; 156 Yao, Seol, Mi, Robbins (CR193) 2006; 8 Gu (CR105) 2012; 2012 Pierer (CR143) 2007; 46 Xie (CR49) 2014; 192 Shaw, Wang, Ito, Arima, Liu (CR118) 2010; 115 Eissner (CR27) 2004; 15 Chen (CR41) 2012; 51 Nocentini, Ronchetti, Petrillo, Riccardi (CR99) 2012; 165 Sun (CR128) 2002; 8 Gourh (CR71) 2010; 69 Davis (CR46) 2001; 28 Law, Grewal (CR29) 2009; 647 Park (CR111) 2014; 53 Joo (CR42) 2013; 52 Bae (CR102) 2007; 148 Splawski, Lipsky (CR31) 1994; 145 Richard (CR22) 2016; 8 Xu, Chen, Li, Ren, Ye (CR94) 2015; 35 Ogasawara (CR197) 1993; 364 Park (CR165) 2013; 183 Audo (CR202) 2014; 66 Petreaca (CR139) 2012; 20 Wang (CR187) 1999; 98 Janssen (CR179) 2005; 434 Ramaswamy (CR178) 2011; 18 Schnitzer, Marks (CR18) 2015; 23 Fava (CR145) 2003; 171 Kan (CR20) 2016; 11 Croft (CR54) 2010; 28 Gommerman, Browning (CR137) 2003; 3 Watanabe-Fukunaga, Brannan, Copeland, Jenkins, Nagata (CR181) 1992; 356 Jacquemin (CR61) 2015; 42 Ichikawa (CR188) 2003; 171 Foell (CR130) 2003; 111 Jacobi (CR115) 2010; 69 Shock (CR50) 2015; 17 Osawa, Takami, Shiozawa, Hashiramoto, Shiozawa (CR90) 2004; 5 Seo (CR125) 2004; 10 Bamias (CR83) 2013; 147 Xia (CR168) 2012; 145 Patel (CR104) 2005; 35 Liu (CR192) 2003; 112 Al-Lamki (CR97) 2012; 180 Kalliolias, Ivashkiv (CR7) 2016; 12 Cessak (CR8) 2014; 66 Peter, Krammer (CR177) 2003; 10 Greenberg (CR135) 2012; 71 Schreiber (CR224) 2010; 120 Nagy, Penninger (CR15) 2015; 61 Wang (CR88) 2013; 191 Cordoba (CR51) 2015; 15 Ramaswamy, Siegel (CR180) 2007; 26 Bamias (CR92) 2011; 20 Sanchez-Paulete (CR122) 2016; 46 CR19 Nolte, van Olffen, van Gisbergen, van Lier (CR107) 2009; 229 Mariette (CR207) 2015; 74 Kennedy (CR136) 2014; 16 da Silva Antunes, Madge, Soroosh, Tocker, Croft (CR141) 2015; 195 Tsakiri, Papadopoulos, Denis, Mitsikostas, Kollias (CR222) 2012; 42 Wei, Chang, Wei (CR16) 2015; 76 Li (CR93) 2014; 306 Croft (CR6) 2012; 33 Burkly, Michaelson, Zheng (CR152) 2011; 244 Fava, Browning, Gatumu, Skarstein, Bolstad (CR147) 2011; 691 Gwyer Findlay (CR56) 2014; 111 Wang (CR101) 2012; 180 Nordmark (CR70) 2011; 12 Wang (CR89) 2014; 66 Wen (CR170) 2013; 43 Orozco (CR40) 2010; 69 Snell, Lin, McPherson, Moraes, Watts (CR121) 2011; 244 Schmitz (CR198) 2003; 171 Yoshioka (CR55) 2000; 30 Doerner (CR171) 2015; 135 Puliaeva, Puliaev, Shustov, Haas, Via (CR200) 2008; 181 Fukasawa (CR211) 2003; 33 Croft (CR5) 2009; 9 Liu, Chao, Wang, Lei (CR212) 2001; 34 Bresson, Fousteri, Manenkova, Croft, von Herrath (CR227) 2011; 37 Herro, Antunes Rda, Aguilera, Tamada, Croft (CR144) 2015; 135 Font (CR114) 1996; 81 Garcia, Liz, Gomez-Reino, Conde (CR190) 2010; 12 Sawalha, Jeffries (CR117) 2007; 37 Meylan (CR74) 2008; 29 Boumpas (CR45) 2003; 48 Campbell (CR173) 2006; 176 Sun (CR84) 2013; 42 Edwards (CR142) 2006; 54 Farres, Al-Zifzaf, Aly, Abd Raboh (CR65) 2011; 31 Qin (CR67) 2011; 22 Wilde (CR73) 2009; 24 Herro, Croft (CR134) 2016; 104 van der Linden (CR39) 2009; 60 Chen (CR220) 2013; 190 Burkly (CR151) 2014; 26 Vincent, Morand, Schneider, Mackay (CR17) 2014; 10 Oelke (CR116) 2004; 50 Komura (CR72) 2008; 35 Yin (CR120) 2010; 59 Wolf (CR225) 2012; 94 Jin (CR194) 2010; 332 Genovese (CR215) 2004; 50 Perper (CR163) 2006; 177 Stohl (CR208) 2013; 40 Allen (CR30) 1993; 259 CR53 CR52 Oflazoglu (CR108) 2009; 183 Micheau, Tschopp (CR26) 2003; 114 Chen, Oppenheim (CR13) 2016; 12 Li (CR203) 2014; 290 Bull (CR87) 2008; 205 Anders, Subudhi, Wang, Pfeffer, Fu (CR140) 2005; 175 Meighan-Mantha (CR154) 1999; 274 Zhao (CR169) 2007; 179 Bienkowska (CR150) 2014; 9 Seleznik (CR148) 2016; 89 Lamhamedi-Cherradi, Zheng, Maguschak, Peschon, Chen (CR185) 2003; 4 Jung, Choi, Choi, Kwon (CR124) 2004; 36 Locksley, Killeen, Lenardo (CR3) 2001; 104 Al-Lamki (CR95) 2003; 163 Rosenthal, Lin (CR21) 2014; 220 Herro, Da Silva Antunes, Aguilera, Tamada, Croft (CR149) 2015; 136 Cassatella (CR80) 2007; 178 Cao, Xu, Huang, Li (CR85) 2014; 43 Bamias (CR81) 2008; 129 Novoyatleva, Sajjad, Engel (CR161) 2014; 5 Raychaudhuri (CR38) 2008; 40 Pappu (CR75) 2008; 205 Gao (CR174) 2009; 46 Rieux-Laucat (CR182) 1995; 268 Jiang (CR119) 2012; 143 van Kuijk (CR156) 2010; 69 Shi (CR195) 2014; 34 Placke, Kopp, Salih (CR98) 2010; 2010 Foell (CR129) 2003; 987 Mohan, Shi, Laman, Datta (CR35) 1995; 154 Foell (CR126) 2004; 113 LeBlanc, Ashkenazi (CR186) 2003; 10 Grewal, Flavell (CR32) 1996; 153 McCann (CR221) 2014; 66 Wisniacki (CR166) 2013; 35 Dharmapatni (CR157) 2011; 13 Maksimow, Soderstrom, Jalkanen, Eriksson, Hanninen (CR199) 2006; 79 Fang, Adkins, Deyev, Podack (CR76) 2008; 205 Chen (CR43) 2015; 16 Ray, Basu, Williams, Salzman, Dittel (CR228) 2012; 188 Kamata (CR164) 2006; 177 Cunninghame Graham (CR66) 2008; 40 Neve, Corrado, Cantatore (CR191) 2014; 14 Swaak, Hintzen, Huysen, van den Brink, Smeenk (CR113) 1995; 14 Fisher (CR183) 1995; 81 Wiley (CR153) 2001; 15 Zinovieva (CR91) 2009; 5 Dolff (CR64) 2010; 12 Shui, Steinberg, Kronenberg (CR133) 2011; 89 Park, Chung, Park, Lee (CR155) 2008; 37 Abo-Elenein, Shaaban, Gheith (CR63) 2008; 15 Stohl (CR10) 2014; 18 Zaheer, LeBoff, Lewiecki (CR14) 2015; 11 Early, Zhao, Burns (CR36) 1996; 157 Aten (CR60) 2000; 11 Schwartz (CR175) 2009; 11 Zhang, Wang, Wang, Zhang, Yu (CR196) 2012; 50 Cuzzocrea (CR100) 2005; 19 Vinay, Choi, Kim, Choi, Kwon (CR127) 2007; 122 Sanz (CR167) 2008; 19 Xia (CR172) 2015; 26 Vinay, Kim, Choi, Kwon (CR223) 2009; 39 Bae (CR103) 2008; 45 Bodmer, Schneider, Tschopp (CR23) 2002; 27 Sanz, Yasothan, Kirkpatrick (CR205) 2011; 10 Shui (CR138) 2012; 488 CR176 Michel, Langstein, Hofstadter, Schwarz (CR123) 1998; 28 Durie (CR34) 1993; 261 Richard (CR78) 2015; 98 Drappa, Vaishnaw, Sullivan, Chu, Elkon (CR184) 1996; 335 Xia, Shen, Xiao, Lu (CR158) 2011; 53 Shih (CR213) 2014; 7 Carrier (CR230) 2012; 42 Walsh, Choi (CR9) 2014; 5 Patschan (CR62) 2006; 145 Chicheportiche (CR159) 1997; 272 Gatumu (CR146) 2009; 11 Watts (CR209) 2005; 23 Monaco, Nanchahal, Taylor, Feldmann (CR204) 2015; 27 DJ Nowakowska (BFnrrheum201722_CR229) 2016; 196 L Gu (BFnrrheum201722_CR105) 2012; 2012 RA Anders (BFnrrheum201722_CR140) 2005; 175 BP Pappu (BFnrrheum201722_CR75) 2008; 205 A Abo-Elenein (BFnrrheum201722_CR63) 2008; 15 G Bamias (BFnrrheum201722_CR92) 2011; 20 MN Farres (BFnrrheum201722_CR65) 2011; 31 MA Cassatella (BFnrrheum201722_CR80) 2007; 178 X Sun (BFnrrheum201722_CR84) 2013; 42 M Croft (BFnrrheum201722_CR54) 2010; 28 KC Kalunian (BFnrrheum201722_CR47) 2002; 46 M Pierer (BFnrrheum201722_CR143) 2007; 46 MJ Bull (BFnrrheum201722_CR87) 2008; 205 C Monaco (BFnrrheum201722_CR204) 2015; 27 M Ramaswamy (BFnrrheum201722_CR180) 2007; 26 YH Lee (BFnrrheum201722_CR44) 2015; 24 J Zhang (BFnrrheum201722_CR82) 2009; 183 C Mohan (BFnrrheum201722_CR35) 1995; 154 S Cuzzocrea (BFnrrheum201722_CR100) 2005; 19 Y Chicheportiche (BFnrrheum201722_CR159) 1997; 272 M Croft (BFnrrheum201722_CR11) 2013; 12 I Sanz (BFnrrheum201722_CR205) 2011; 10 FB Vincent (BFnrrheum201722_CR17) 2014; 10 AW van Kuijk (BFnrrheum201722_CR156) 2010; 69 TH Watts (BFnrrheum201722_CR209) 2005; 23 LC Burkly (BFnrrheum201722_CR151) 2014; 26 FE McCann (BFnrrheum201722_CR221) 2014; 66 F Cordoba (BFnrrheum201722_CR51) 2015; 15 D Wolf (BFnrrheum201722_CR225) 2012; 94 G Orozco (BFnrrheum201722_CR40) 2010; 69 RC Allen (BFnrrheum201722_CR30) 1993; 259 S Zaheer (BFnrrheum201722_CR14) 2015; 11 M Maksimow (BFnrrheum201722_CR199) 2006; 79 J Wen (BFnrrheum201722_CR170) 2013; 43 S Campbell (BFnrrheum201722_CR173) 2006; 176 L Xia (BFnrrheum201722_CR158) 2011; 53 E Zinovieva (BFnrrheum201722_CR91) 2009; 5 F Caso (BFnrrheum201722_CR12) 2015; 15 LM Snell (BFnrrheum201722_CR121) 2011; 244 JW Shui (BFnrrheum201722_CR133) 2011; 89 EM Bae (BFnrrheum201722_CR103) 2008; 45 J Wang (BFnrrheum201722_CR187) 1999; 98 N Tsakiri (BFnrrheum201722_CR222) 2012; 42 I Schmitz (BFnrrheum201722_CR198) 2003; 171 Q Yao (BFnrrheum201722_CR193) 2006; 8 CH Jin (BFnrrheum201722_CR194) 2010; 332 SK Seo (BFnrrheum201722_CR125) 2004; 10 G Nordmark (BFnrrheum201722_CR70) 2011; 12 MA Nolte (BFnrrheum201722_CR107) 2009; 229 L Li (BFnrrheum201722_CR93) 2014; 306 A Shock (BFnrrheum201722_CR50) 2015; 17 M Croft (BFnrrheum201722_CR4) 2003; 3 J Bienkowska (BFnrrheum201722_CR150) 2014; 9 K Ichikawa (BFnrrheum201722_CR188) 2003; 171 YB Joo (BFnrrheum201722_CR42) 2013; 52 A Neve (BFnrrheum201722_CR191) 2014; 14 R Giacomelli (BFnrrheum201722_CR58) 2001; 19 V Nagy (BFnrrheum201722_CR15) 2015; 61 O Micheau (BFnrrheum201722_CR26) 2003; 114 E Bae (BFnrrheum201722_CR102) 2007; 148 BFnrrheum201722_CR19 M Weinblatt (BFnrrheum201722_CR216) 2007; 66 X Mariette (BFnrrheum201722_CR207) 2015; 74 M Feldman (BFnrrheum201722_CR2) 1998; 30 S Wang (BFnrrheum201722_CR101) 2012; 180 M Patel (BFnrrheum201722_CR104) 2005; 35 G Eissner (BFnrrheum201722_CR27) 2004; 15 E Soforo (BFnrrheum201722_CR219) 2010; 37 N Pundt (BFnrrheum201722_CR189) 2009; 11 R Audo (BFnrrheum201722_CR202) 2014; 66 S Garcia (BFnrrheum201722_CR190) 2010; 12 R Herro (BFnrrheum201722_CR144) 2015; 135 W Stohl (BFnrrheum201722_CR10) 2014; 18 JK Park (BFnrrheum201722_CR111) 2014; 53 K Murata (BFnrrheum201722_CR68) 2002; 169 J Drappa (BFnrrheum201722_CR184) 1996; 335 R da Silva Antunes (BFnrrheum201722_CR141) 2015; 195 S Raychaudhuri (BFnrrheum201722_CR38) 2008; 40 W Zhang (BFnrrheum201722_CR196) 2012; 50 G Bamias (BFnrrheum201722_CR81) 2008; 129 AL Peters (BFnrrheum201722_CR28) 2009; 21 E Oflazoglu (BFnrrheum201722_CR108) 2009; 183 JK Laustsen (BFnrrheum201722_CR69) 2014; 16 BFnrrheum201722_CR176 TJ Schnitzer (BFnrrheum201722_CR18) 2015; 23 LC Burkly (BFnrrheum201722_CR152) 2011; 244 SE Lamhamedi-Cherradi (BFnrrheum201722_CR185) 2003; 4 MP van der Linden (BFnrrheum201722_CR39) 2009; 60 K Oelke (BFnrrheum201722_CR116) 2004; 50 N Wisniacki (BFnrrheum201722_CR166) 2013; 35 G Nocentini (BFnrrheum201722_CR99) 2012; 165 JM Chen (BFnrrheum201722_CR43) 2015; 16 JL Browning (BFnrrheum201722_CR131) 2008; 223 JW Shui (BFnrrheum201722_CR138) 2012; 488 JH Xie (BFnrrheum201722_CR49) 2014; 192 B Beutler (BFnrrheum201722_CR1) 1985; 316 J Aten (BFnrrheum201722_CR60) 2000; 11 SL Kan (BFnrrheum201722_CR20) 2016; 11 GD Kalliolias (BFnrrheum201722_CR7) 2016; 12 P Gourh (BFnrrheum201722_CR71) 2010; 69 K Komura (BFnrrheum201722_CR72) 2008; 35 J Silke (BFnrrheum201722_CR24) 2010; 17 MK Gatumu (BFnrrheum201722_CR146) 2009; 11 JR Edwards (BFnrrheum201722_CR142) 2006; 54 G Seleznik (BFnrrheum201722_CR148) 2016; 89 RL Meighan-Mantha (BFnrrheum201722_CR154) 1999; 274 HX Gao (BFnrrheum201722_CR174) 2009; 46 A Rosenthal (BFnrrheum201722_CR21) 2014; 220 C Fukasawa (BFnrrheum201722_CR211) 2003; 33 M Gattorno (BFnrrheum201722_CR112) 2002; 20 C Jacquemin (BFnrrheum201722_CR61) 2015; 42 K Osawa (BFnrrheum201722_CR90) 2004; 5 G Cessak (BFnrrheum201722_CR8) 2014; 66 ME Peter (BFnrrheum201722_CR177) 2003; 10 F Meylan (BFnrrheum201722_CR74) 2008; 29 JL Foell (BFnrrheum201722_CR126) 2004; 113 T Novoyatleva (BFnrrheum201722_CR161) 2014; 5 Y Xia (BFnrrheum201722_CR172) 2015; 26 W Stohl (BFnrrheum201722_CR218) 2013; 9 T Placke (BFnrrheum201722_CR98) 2010; 2010 M Croft (BFnrrheum201722_CR6) 2012; 33 S Patschan (BFnrrheum201722_CR62) 2006; 145 EC Wang (BFnrrheum201722_CR89) 2014; 66 F Meylan (BFnrrheum201722_CR77) 2011; 244 AC Richard (BFnrrheum201722_CR78) 2015; 98 HJ Anders (BFnrrheum201722_CR214) 2016; 12 IS Grewal (BFnrrheum201722_CR32) 1996; 153 I Puliaeva (BFnrrheum201722_CR200) 2008; 181 SR Wiley (BFnrrheum201722_CR153) 2001; 15 F Chen (BFnrrheum201722_CR41) 2012; 51 DS Vinay (BFnrrheum201722_CR223) 2009; 39 CL Law (BFnrrheum201722_CR29) 2009; 647 JL Ferrant (BFnrrheum201722_CR48) 2004; 16 BFnrrheum201722_CR52 BFnrrheum201722_CR53 M Croft (BFnrrheum201722_CR210) 2014; 26 WD Xu (BFnrrheum201722_CR94) 2015; 35 DS Vinay (BFnrrheum201722_CR127) 2007; 122 JL Doerner (BFnrrheum201722_CR171) 2015; 135 R Horai (BFnrrheum201722_CR57) 2004; 114 H Jiang (BFnrrheum201722_CR119) 2012; 143 J Font (BFnrrheum201722_CR114) 1996; 81 MF Liu (BFnrrheum201722_CR212) 2001; 34 RM Locksley (BFnrrheum201722_CR3) 2001; 104 WW Lee (BFnrrheum201722_CR110) 2007; 179 AC Richard (BFnrrheum201722_CR22) 2016; 8 X Chen (BFnrrheum201722_CR220) 2013; 190 F Wei (BFnrrheum201722_CR16) 2015; 76 J Ogasawara (BFnrrheum201722_CR197) 1993; 364 EP Boot (BFnrrheum201722_CR59) 2005; 7 RA Fava (BFnrrheum201722_CR145) 2003; 171 JS Park (BFnrrheum201722_CR165) 2013; 183 Z Liu (BFnrrheum201722_CR192) 2003; 112 X Li (BFnrrheum201722_CR203) 2014; 290 S Kamijo (BFnrrheum201722_CR160) 2008; 47 JB Splawski (BFnrrheum201722_CR31) 1994; 145 FH Durie (BFnrrheum201722_CR34) 1993; 261 AC Ucero (BFnrrheum201722_CR162) 2013; 1832 MH Blotta (BFnrrheum201722_CR33) 1996; 156 W Stohl (BFnrrheum201722_CR208) 2013; 40 R Herro (BFnrrheum201722_CR149) 2015; 136 MJ Citores (BFnrrheum201722_CR37) 2004; 63 AB Sanz (BFnrrheum201722_CR167) 2008; 19 F Rieux-Laucat (BFnrrheum201722_CR182) 1995; 268 JL Gommerman (BFnrrheum201722_CR137) 2003; 3 HN LeBlanc (BFnrrheum201722_CR186) 2003; 10 L Cao (BFnrrheum201722_CR85) 2014; 43 H Yin (BFnrrheum201722_CR120) 2010; 59 S Dolff (BFnrrheum201722_CR64) 2010; 12 TH Schreiber (BFnrrheum201722_CR224) 2010; 120 D Bresson (BFnrrheum201722_CR227) 2011; 37 Z Zhao (BFnrrheum201722_CR169) 2007; 179 AH Sawalha (BFnrrheum201722_CR117) 2007; 37 L Fang (BFnrrheum201722_CR76) 2008; 205 K Kamata (BFnrrheum201722_CR164) 2006; 177 X Chen (BFnrrheum201722_CR13) 2016; 12 GH Fisher (BFnrrheum201722_CR183) 1995; 81 M Croft (BFnrrheum201722_CR5) 2009; 9 J Michel (BFnrrheum201722_CR123) 1998; 28 RS Al-Lamki (BFnrrheum201722_CR95) 2003; 163 J Foell (BFnrrheum201722_CR130) 2003; 111 MC Park (BFnrrheum201722_CR155) 2008; 37 Y Xia (BFnrrheum201722_CR168) 2012; 145 DT Boumpas (BFnrrheum201722_CR45) 2003; 48 M Ramaswamy (BFnrrheum201722_CR178) 2011; 18 J Foell (BFnrrheum201722_CR129) 2003; 987 N Schwartz (BFnrrheum201722_CR175) 2009; 11 R Watanabe-Fukunaga (BFnrrheum201722_CR181) 1992; 356 J Shaw (BFnrrheum201722_CR118) 2010; 115 Q Shi (BFnrrheum201722_CR195) 2014; 34 X Gan (BFnrrheum201722_CR106) 2013; 2013 ML Petreaca (BFnrrheum201722_CR139) 2012; 20 B Wilde (BFnrrheum201722_CR73) 2009; 24 T Yoshioka (BFnrrheum201722_CR55) 2000; 30 M Karin (BFnrrheum201722_CR25) 2009; 228 PP Tak (BFnrrheum201722_CR109) 1996; 80 MC Walsh (BFnrrheum201722_CR9) 2014; 5 A Ray (BFnrrheum201722_CR228) 2012; 188 GS Early (BFnrrheum201722_CR36) 1996; 157 E Gwyer Findlay (BFnrrheum201722_CR56) 2014; 111 Y Sun (BFnrrheum201722_CR128) 2002; 8 DQ Shih (BFnrrheum201722_CR79) 2011; 691 X Wang (BFnrrheum201722_CR88) 2013; 191 JL Bodmer (BFnrrheum201722_CR23) 2002; 27 Y Carrier (BFnrrheum201722_CR230) 2012; 42 JC Davis (BFnrrheum201722_CR46) 2001; 28 HW Jung (BFnrrheum201722_CR124) 2004; 36 R Furie (BFnrrheum201722_CR206) 2011; 63 M Aringer (BFnrrheum201722_CR217) 2012; 11 R Herro (BFnrrheum201722_CR134) 2016; 104 AJ Swaak (BFnrrheum201722_CR113) 1995; 14 RS Al-Lamki (BFnrrheum201722_CR96) 2008; 19 AA Dharmapatni (BFnrrheum201722_CR157) 2011; 13 CA Klebanoff (BFnrrheum201722_CR201) 2016; 126 DS Cunninghame Graham (BFnrrheum201722_CR66) 2008; 40 W Qin (BFnrrheum201722_CR67) 2011; 22 G Bamias (BFnrrheum201722_CR83) 2013; 147 DQ Shih (BFnrrheum201722_CR213) 2014; 7 CE Ruby (BFnrrheum201722_CR226) 2009; 183 WP Kennedy (BFnrrheum201722_CR136) 2014; 16 MC Genovese (BFnrrheum201722_CR215) 2004; 50 AM Jacobi (BFnrrheum201722_CR115) 2010; 69 AR Sanchez-Paulete (BFnrrheum201722_CR122) 2016; 46 JD Greenberg (BFnrrheum201722_CR135) 2012; 71 RA Fava (BFnrrheum201722_CR147) 2011; 691 Z Xiu (BFnrrheum201722_CR86) 2015; 72 RS Al-Lamki (BFnrrheum201722_CR97) 2012; 180 CF Ware (BFnrrheum201722_CR132) 2009; 647 SJ Perper (BFnrrheum201722_CR163) 2006; 177 EM Janssen (BFnrrheum201722_CR179) 2005; 434 16330535 - J Leukoc Biol. 2006 Feb;79(2):369-77 26804020 - Nat Rev Nephrol. 2016 Apr;12(4):205-16 11728344 - Immunity. 2001 Nov;15(5):837-46 26139432 - Am J Transplant. 2015 Nov;15(11):2825-36 19778912 - Ann Rheum Dis. 2010 Mar;69(3):550-5 25614274 - Expert Opin Drug Metab Toxicol. 2015 Mar;11(3):461-70 22902792 - Transplantation. 2012 Sep 27;94(6):569-74 17056575 - J Immunol. 2006 Nov 1;177(9):6433-9 24347569 - Ann Rheum Dis. 2015 Mar;74(3):526-31 19196727 - Ann Rheum Dis. 2010 Jan;69(1):305-8 26748035 - Pharmacol Res. 2016 Feb;104:151-5 21245596 - Ann Saudi Med. 2011 Jan-Feb;31(1):29-34 17513783 - J Immunol. 2007 Jun 1;178(11):7325-33 21106644 - J Leukoc Biol. 2011 Apr;89(4):517-23 15188362 - Arthritis Rheum. 2004 Jun;50(6):1850-60 23334208 - Nat Rev Drug Discov. 2013 Feb;12(2):147-68 21164519 - Cell Death Differ. 2011 Apr;18(4):712-20 23311967 - Scand J Rheumatol. 2013;42(2):97-101 19760072 - Adv Exp Med Biol. 2009;647:146-55 18411341 - J Exp Med. 2008 May 12;205(5):1037-48 25359291 - Arthritis Res Ther. 2014 Oct 30;16(5):474 24817699 - Rheumatology (Oxford). 2014 Oct;53(10):1896-900 26773716 - Eur J Immunol. 2016 Mar;46(3):513-22 19426224 - Immunol Rev. 2009 May;229(1):216-31 21143648 - Pediatr Allergy Immunol. 2011 Feb;22(1 Pt 1):54-9 22017434 - Immunol Rev. 2011 Nov;244(1):99-114 15744305 - Nature. 2005 Mar 3;434(7029):88-93 19319144 - Nat Rev Immunol. 2009 Apr;9(4):271-85 12974479 - Nat Rev Immunol. 2003 Aug;3(8):642-55 12816989 - J Immunol. 2003 Jul 1;171(1):115-26 17608689 - Immunology. 2007 Nov;122(3):394-400 18757243 - Clin Immunol. 2008 Nov;129(2):249-55 18794853 - Nat Genet. 2008 Oct;40(10):1216-23 15448685 - Nat Med. 2004 Oct;10(10):1088-94 16935912 - Ann Rheum Dis. 2007 Feb;66(2):228-34 21435232 - Arthritis Res Ther. 2011 Mar 24;13(2):R51 18025243 - J Immunol. 2007 Dec 1;179(11):7949-58 10412980 - Cell. 1999 Jul 9;98 (1):47-58 17675524 - J Immunol. 2007 Aug 15;179(4):2609-15 27748055 - Arthritis Rheumatol. 2016 Oct 16;:null 7540117 - Cell. 1995 Jun 16;81(6):935-46 20653937 - Arthritis Res Ther. 2010;12(4):R150 25078097 - Arthritis Rheumatol. 2014 Dec;66(12):3289-99 12508783 - Clin Exp Rheumatol. 2002 Nov-Dec;20(6):863-6 14597760 - J Clin Invest. 2003 Nov;112(9):1332-41 18465450 - Scand J Rheumatol. 2008 May-Jun;37(3):173-8 15578092 - J Clin Invest. 2004 Dec;114(11):1603-11 22325471 - Mol Immunol. 2012 Mar;50(3):150-9 15241467 - Genes Immun. 2004 Sep;5(6):439-43 14962968 - Ann Rheum Dis. 2004 Mar;63(3):310-7 24613728 - Semin Immunol. 2014 Jun;26(3):183-90 9485208 - Eur J Immunol. 1998 Jan;28(1):290-5 19760064 - Adv Exp Med Biol. 2009;647:8-36 23578591 - J Autoimmun. 2013 Jun;43:44-54 10551889 - J Biol Chem. 1999 Nov 12;274(46):33166-76 16285015 - Eur J Immunol. 2005 Dec;35(12):3581-90 19680262 - Cell Death Differ. 2010 Jan;17 (1):35-45 22063316 - J Autoimmun. 2011 Dec;37(4):342-51 12847280 - J Immunol. 2003 Jul 15;171(2):1061-9 21619949 - Autoimmun Rev. 2012 Mar;11(5):321-5 24614588 - Nat Rev Rheumatol. 2014 Jun;10(6):365-73 23845567 - Am J Pathol. 2013 Sep;183(3):857-67 20890040 - J Clin Invest. 2010 Oct;120(10):3629-40 12370402 - J Immunol. 2002 Oct 15;169(8):4628-36 18059267 - Nat Genet. 2008 Jan;40(1):83-9 26474561 - BMC Genet. 2015 Oct 16;16:121 25270074 - J Am Soc Nephrol. 2015 May;26(5):1053-70 15771565 - Annu Rev Immunol. 2005;23:23-68 14515263 - Eur J Immunol. 2003 Oct;33(10):2792-800 22294625 - Ann Rheum Dis. 2012 Jul;71(7):1134-42 22169337 - Trends Immunol. 2012 Mar;33(3):144-52 15146410 - Arthritis Rheum. 2004 May;50(5):1412-9 26335795 - Arthritis Res Ther. 2015 Sep 03;17:234 25411043 - Int Immunol. 2015 Jan;27(1):55-62 8929361 - N Engl J Med. 1996 Nov 28;335(22):1643-9 24850426 - Mucosal Immunol. 2014 Nov;7(6):1492-503 20306696 - Egypt J Immunol. 2008;15(2):135-43 21792649 - Rheumatol Int. 2014 Jan;34(1):51-7 7679801 - Science. 1993 Feb 12;259(5097):990-3 25789702 - J Invest Dermatol. 2015 Aug;135(8):2109-18 16879242 - Clin Exp Immunol. 2006 Aug;145(2):235-42 12655296 - Cell Death Differ. 2003 Jan;10(1):66-75 25368616 - Front Immunol. 2014 Oct 20;5:511 7689748 - Science. 1993 Sep 3;261(5126):1328-30 17429846 - Eur J Immunol. 2007 May;37(5):1407-13 23748045 - Biochim Biophys Acta. 2013 Oct;1832(10):1744-55 8816428 - J Immunol. 1996 Oct 1;157(7):3159-64 20724115 - J Dermatol Sci. 2010 Sep;59(3):198-203 16002734 - J Immunol. 2005 Jul 15;175(2):1295-300 19644859 - Arthritis Rheum. 2009 Aug;60(8):2242-7 7527580 - Res Immunol. 1994 Mar-Apr;145(3):226-34; discussion 244-9 25720990 - Gerontology. 2015;61(6):534-42 17426140 - Rheumatology (Oxford). 2007 Jul;46(7):1063-70 21672030 - Exp Dermatol. 2011 Sep;20(9):725-31 23256180 - Rheumatology (Oxford). 2013 Apr;52(4):623-30 24140642 - J Immunol. 2013 Dec 1;191(11):5420-9 19595612 - Semin Immunol. 2009 Oct;21(5):293-300 22105853 - Eur J Immunol. 2012 Feb;42(2):403-12 11069062 - Eur J Immunol. 2000 Oct;30(10):2815-23 7529804 - J Immunol. 1995 Feb 1;154(3):1470-80 21190865 - Cytokine. 2011 Mar;53(3):289-91 26070486 - Immunity. 2015 Jun 16;42(6):1159-70 20936139 - Clin Dev Immunol. 2010;2010:239083 27586383 - Nat Rev Rheumatol. 2016 Nov;12 (11):625-626 19933369 - J Pharmacol Exp Ther. 2010 Mar;332(3):858-65 12875962 - Am J Pathol. 2003 Aug;163(2):401-11 23251213 - Clin Dev Immunol. 2012;2012:265868 25826425 - J Invest Dermatol. 2015 Aug;135(8):1986-95 23275079 - Clin Exp Med. 2014 May;14(2):115-20 25527221 - Osteoarthritis Cartilage. 2015 Jan;23 Suppl 1:S8-17 24521424 - Expert Opin Ther Targets. 2014 Apr;18(4):473-89 24018550 - Nat Rev Rheumatol. 2013 Dec;9(12):705-20 24670803 - J Immunol. 2014 May 1;192(9):4083-92 19785730 - Arthritis Res Ther. 2009;11(5):R143 19543369 - PLoS Genet. 2009 Jun;5(6):e1000528 18723571 - Nephrol Dial Transplant. 2009 Jan;24(1):161-71 24636536 - Semin Immunol. 2014 Jun;26(3):229-36 19710474 - J Immunol. 2009 Sep 15;183(6):3770-7 20187936 - Arthritis Res Ther. 2010;12(1):R33 26657860 - J Clin Invest. 2016 Jan;126(1):318-34 12974476 - Nat Rev Immunol. 2003 Aug;3(8):609-20 20307208 - Annu Rev Immunol. 2010;28:57-78 25044706 - Arthritis Rheumatol. 2014 Oct;66(10):2762-72 11407087 - Clin Exp Rheumatol. 2001 May-Jun;19(3):317-20 22368274 - J Immunol. 2012 Apr 1;188(7):3188-98 15466914 - Int Immunol. 2004 Nov;16(11):1583-94 23598291 - Clin Immunol. 2013 May;147(2):144-50 19196465 - Arthritis Res Ther. 2009;11(1):R16 26810223 - J Immunol. 2016 Mar 1;196 (5):2145-52 12577054 - Nat Immunol. 2003 Mar;4(3):255-60 18310134 - Rheumatology (Oxford). 2008 Apr;47(4):442-50 20139096 - Blood. 2010 Apr 15;115(15):3051-7 19786544 - J Immunol. 2009 Oct 15;183(8):4853-7 18287561 - J Am Soc Nephrol. 2008 May;19(5):953-60 23928094 - Clin Ther. 2013 Aug;35(8):1137-49 21532557 - Nat Rev Drug Discov. 2011 May;10(5):335-6 22214837 - Am J Pathol. 2012 Mar;180(3):1059-67 26209626 - J Immunol. 2015 Sep 1;195(5):2429-41 10906156 - J Am Soc Nephrol. 2000 Aug;11(8):1426-38 22801499 - Nature. 2012 Aug 9;488(7410):222-5 16507116 - Arthritis Res Ther. 2006;8(1):R16 21153342 - Adv Exp Med Biol. 2011;691:383-90 19147618 - Ann Rheum Dis. 2010 Jan;69(1):301-4 19233685 - Cytokine. 2009 Apr;46(1):24-35 11905840 - Autoimmunity. 2001;34(2):107-13 19499519 - Eur J Immunol. 2009 Jun;39(6):1552-63 18411337 - J Exp Med. 2008 May 12;205(5):1049-62 17359498 - Clin Exp Immunol. 2007 Jun;148(3):410-8 25359150 - Arthritis Res Ther. 2014 Oct 30;16(5):467 9865320 - Transplant Proc. 1998 Dec;30(8):4126-7 22330679 - Am J Pathol. 2012 Apr;180(4):1454-64 12632425 - Arthritis Rheum. 2003 Mar;48(3):719-27 25680454 - J Allergy Clin Immunol. 2015 Sep;136(3):757-68 18571443 - Immunity. 2008 Jul 18;29(1):79-89 25405351 - PLoS One. 2014 Nov 18;9(11):e112545 18824582 - J Exp Med. 2008 Oct 27;205(11):2457-64 12483729 - Arthritis Rheum. 2002 Dec;46(12):3251-8 16424220 - J Immunol. 2006 Feb 1;176(3):1889-98 19435719 - Ann Rheum Dis. 2010 May;69(5):813-6 19222863 - Arthritis Res Ther. 2009;11(1):R24 8938100 - Clin Immunol Immunopathol. 1996 Dec;81(3):239-43 8617933 - J Immunol. 1996 May 1;156(9):3133-40 25149988 - Pharmacol Rep. 2014 Oct;66(5):836-44 12655293 - Cell Death Differ. 2003 Jan;10(1):26-35 26656660 - Nat Rev Rheumatol. 2016 Jan;12(1):49-62 23277487 - J Immunol. 2013 Feb 1;190(3):1076-84 15450251 - Cytokine Growth Factor Rev. 2004 Oct;15(5):353-66 11239407 - Cell. 2001 Feb 23;104(4):487-501 12750400 - J Clin Invest. 2003 May;111(10):1505-18 16888023 - J Immunol. 2006 Aug 15;177(4):2610-20 22678896 - Eur J Immunol. 2012 Jun;42(6):1393-404 22982296 - Clin Immunol. 2012 Nov;145(2):108-21 18941180 - J Immunol. 2008 Nov 1;181(9):5912-29 17602748 - Mol Immunol. 2008 Jan;45(2):523-33 1372394 - Nature. 1992 Mar 26;356(6367):314-7 11196549 - J Rheumatol. 2001 Jan;28(1):95-101 25647275 - Cytokine. 2015 Apr;72(2):185-9 27435189 - Genome Med. 2016 Jul 19;8(1):76 18235096 - J Am Soc Nephrol. 2008 Apr;19(4):695-703 19290931 - Immunol Rev. 2009 Mar;228(1):225-40 15031666 - Exp Mol Med. 2004 Feb 29;36(1):13-22 9405449 - J Biol Chem. 1997 Dec 19;272(51):32401-10 22029729 - Br J Pharmacol. 2012 Apr;165(7):2089-99 20040644 - J Rheumatol. 2010 Jan;37(1):204-5 20861858 - Genes Immun. 2011 Mar;12(2):100-9 2993897 - Nature. 1985 Aug 8-14;316(6028):552-4 8764557 - Clin Immunol Immunopathol. 1996 Aug;80(2):129-38 25323456 - Expert Opin Biol Ther. 2015 Jan;15(1):1-2 23935647 - Clin Dev Immunol. 2013;2013:340751 22564230 - Wound Repair Regen. 2012 May-Jun;20(3):353-66 16649193 - Arthritis Rheum. 2006 May;54(5):1451-62 12727643 - Ann N Y Acad Sci. 2003 Apr;987:230-5 18613838 - Immunol Rev. 2008 Jun;223:202-20 25200589 - Arch Dermatol Res. 2014 Dec;306(10):927-32 24611063 - Front Immunol. 2014 Feb 11;5:50 25084560 - Cell Immunol. 2014 Aug;290(2):209-16 9010720 - Immunol Rev. 1996 Oct;153:85-106 17521581 - Immunity. 2007 May;26(5):545-7 22127708 - Arthritis Rheum. 2011 Dec;63(12):3918-30 18843780 - J Rheumatol. 2008 Dec;35(12):2359-62 15312139 - Immunology. 2004 Sep;113(1):89-98 22087016 - Rheumatology (Oxford). 2012 Jan;51(1):47-51 26198030 - Cytokine. 2015 Dec;76(2):537-44 22306512 - Clin Immunol. 2012 Apr;143(1):39-44 24469824 - Proc Natl Acad Sci U S A. 2014 Feb 11;111(6):2289-94 26188076 - J Leukoc Biol. 2015 Sep;98(3):333-45 12887920 - Cell. 2003 Jul 25;114(2):181-90 26398497 - Kidney Int. 2016 Jan;89(1):11
References_xml	– volume: 20 start-page: 863 year: 2002 end-page: 866 ident: CR112 article-title: Levels of soluble CD27 in sera and synovial fluid and its expression on memory T cells in patients with juvenile idiopathic arthritides publication-title: Clin. Exp. Rheumatol. – volume: 220 start-page: 497 year: 2014 end-page: 512 ident: CR21 article-title: Modulation of neurotrophin signaling by monoclonal antibodies publication-title: Handb. Exp. Pharmacol. doi: 10.1007/978-3-642-45106-5_19 – volume: 89 start-page: 517 year: 2011 end-page: 523 ident: CR133 article-title: Regulation of inflammation, autoimmunity, and infection immunity by HVEM-BTLA signaling publication-title: J. Leukoc. Biol. doi: 10.1189/jlb.0910528 – volume: 183 start-page: 3770 year: 2009 end-page: 3777 ident: CR108 article-title: Blocking of CD27-CD70 pathway by anti-CD70 antibody ameliorates joint disease in murine collagen-induced arthritis publication-title: J. Immunol. doi: 10.4049/jimmunol.0901637 – volume: 154 start-page: 1470 year: 1995 end-page: 1480 ident: CR35 article-title: Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis publication-title: J. Immunol. – volume: 135 start-page: 1986 year: 2015 end-page: 1995 ident: CR171 article-title: TWEAK/Fn14 signaling involvement in the pathogenesis of cutaneous disease in the MRL/lpr model of spontaneous lupus publication-title: J. Invest. Dermatol. doi: 10.1038/jid.2015.124 – volume: 183 start-page: 4853 year: 2009 end-page: 4857 ident: CR226 article-title: Cutting Edge: OX40 agonists can drive regulatory T cell expansion if the cytokine milieu is right publication-title: J. Immunol. doi: 10.4049/jimmunol.0901112 – volume: 76 start-page: 537 year: 2015 end-page: 544 ident: CR16 article-title: The role of BAFF in the progression of rheumatoid arthritis publication-title: Cytokine doi: 10.1016/j.cyto.2015.07.014 – volume: 15 start-page: 1 year: 2015 end-page: 2 ident: CR12 article-title: Psoriatic arthritis and TNF inhibitors: advances on effectiveness and toxicity publication-title: Expert Opin. Biol. Ther. doi: 10.1517/14712598.2015.973398 – volume: 126 start-page: 318 year: 2016 end-page: 334 ident: CR201 article-title: Memory T cell-driven differentiation of naive cells impairs adoptive immunotherapy publication-title: J. Clin. Invest. doi: 10.1172/JCI81217 – volume: 145 start-page: 235 year: 2006 end-page: 242 ident: CR62 article-title: CD134 expression on CD4+ T cells is associated with nephritis and disease activity in patients with systemic lupus erythematosus publication-title: Clin. Exp. Immunol. doi: 10.1111/j.1365-2249.2006.03141.x – volume: 26 start-page: 1053 year: 2015 end-page: 1070 ident: CR172 article-title: Deficiency of fibroblast growth factor-inducible 14 (fn14) preserves the filtration barrier and ameliorates lupus nephritis publication-title: J. Am. Soc. Nephrol. doi: 10.1681/ASN.2014030233 – volume: 180 start-page: 1454 year: 2012 end-page: 1464 ident: CR97 article-title: DR3 signaling protects against cisplatin nephrotoxicity mediated by tumor necrosis factor publication-title: Am. J. Pathol. doi: 10.1016/j.ajpath.2012.01.003 – volume: 9 start-page: e112545 year: 2014 ident: CR150 article-title: Lymphotoxin-LIGHT pathway regulates the interferon signature in rheumatoid arthritis publication-title: PLoS ONE doi: 10.1371/journal.pone.0112545 – volume: 10 start-page: 26 year: 2003 end-page: 35 ident: CR177 article-title: The CD95(APO-1/Fas) DISC and beyond publication-title: Cell Death Differ. doi: 10.1038/sj.cdd.4401186 – volume: 4 start-page: 255 year: 2003 end-page: 260 ident: CR185 article-title: Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL mice publication-title: Nat. Immunol. doi: 10.1038/ni894 – volume: 148 start-page: 410 year: 2007 end-page: 418 ident: CR102 article-title: Glucocorticoid-induced tumour necrosis factor receptor-related protein-mediated macrophage stimulation may induce cellular adhesion and cytokine expression in rheumatoid arthritis publication-title: Clin. Exp. Immunol. doi: 10.1111/j.1365-2249.2007.03363.x – volume: 10 start-page: 1088 year: 2004 end-page: 1094 ident: CR125 article-title: 4-1BB-mediated immunotherapy of rheumatoid arthritis publication-title: Nat. Med. doi: 10.1038/nm1107 – volume: 12 start-page: 625 year: 2016 end-page: 626 ident: CR13 article-title: Therapy: paradoxical effects of targeting TNF signalling in the treatment of autoimmunity publication-title: Nat. Rev. Rheumatol. doi: 10.1038/nrrheum.2016.145 – volume: 7 start-page: R604 year: 2005 end-page: R615 ident: CR59 article-title: CD134 as target for specific drug delivery to auto-aggressive CD4+ T cells in adjuvant arthritis publication-title: Arthritis Res. Ther. doi: 10.1186/ar1722 – volume: 11 start-page: R143 year: 2009 ident: CR175 article-title: Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study publication-title: Arthritis Res. Ther. doi: 10.1186/ar2816 – volume: 16 start-page: 121 year: 2015 ident: CR43 article-title: The association of CD40 polymorphisms with CD40 serum levels and risk of systemic lupus erythematosus publication-title: BMC Genet. doi: 10.1186/s12863-015-0279-8 – volume: 69 start-page: 301 year: 2010 end-page: 304 ident: CR156 article-title: TWEAK and its receptor Fn14 in the synovium of patients with rheumatoid arthritis compared to psoriatic arthritis and its response to tumour necrosis factor blockade publication-title: Ann. Rheum. Dis. doi: 10.1136/ard.2008.090548 – volume: 115 start-page: 3051 year: 2010 end-page: 3057 ident: CR118 article-title: Plasmacytoid dendritic cells regulate B-cell growth and differentiation via CD70 publication-title: Blood doi: 10.1182/blood-2009-08-239145 – volume: 356 start-page: 314 year: 1992 end-page: 317 ident: CR181 article-title: Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis publication-title: Nature doi: 10.1038/356314a0 – volume: 28 start-page: 290 year: 1998 end-page: 295 ident: CR123 article-title: A soluble form of CD137 (ILA/4-1BB), a member of the TNF receptor family, is released by activated lymphocytes and is detectable in sera of patients with rheumatoid arthritis publication-title: Eur. J. Immunol. doi: 10.1002/(SICI)1521-4141(199801)28:01<290::AID-IMMU290>3.0.CO;2-S – volume: 111 start-page: 1505 year: 2003 end-page: 1518 ident: CR130 article-title: CD137 costimulatory T cell receptor engagement reverses acute disease in lupus-prone NZB x NZW F1 mice publication-title: J. Clin. Invest. doi: 10.1172/JCI200317662 – volume: 192 start-page: 4083 year: 2014 end-page: 4092 ident: CR49 article-title: Engineering of a novel anti-CD40L domain antibody for treatment of autoimmune diseases publication-title: J. Immunol. doi: 10.4049/jimmunol.1303239 – volume: 27 start-page: 19 year: 2002 end-page: 26 ident: CR23 article-title: The molecular architecture of the TNF superfamily publication-title: Trends Biochem. Sci. doi: 10.1016/S0968-0004(01)01995-8 – volume: 40 start-page: 1216 year: 2008 end-page: 1223 ident: CR38 article-title: Common variants at CD40 and other loci confer risk of rheumatoid arthritis publication-title: Nat. Genet. doi: 10.1038/ng.233 – volume: 691 start-page: 383 year: 2011 end-page: 390 ident: CR147 article-title: LTBR-pathway in Sjogren's syndrome: CXCL13 levels and B-cell-enriched ectopic lymphoid aggregates in NOD mouse lacrimal glands are dependent on LTBR publication-title: Adv. Exp. Med. Biol. doi: 10.1007/978-1-4419-6612-4_39 – volume: 14 start-page: 115 year: 2014 end-page: 120 ident: CR191 article-title: TNF-related apoptosis-inducing ligand (TRAIL) in rheumatoid arthritis: what's new? publication-title: Clin. Exp. Med. doi: 10.1007/s10238-012-0226-1 – volume: 178 start-page: 7325 year: 2007 end-page: 7333 ident: CR80 article-title: Soluble TNF-like cytokine (TL1A) production by immune complexes stimulated monocytes in rheumatoid arthritis publication-title: J. Immunol. doi: 10.4049/jimmunol.178.11.7325 – volume: 46 start-page: 24 year: 2009 end-page: 35 ident: CR174 article-title: TNF-like weak inducer of apoptosis (TWEAK) induces inflammatory and proliferative effects in human kidney cells publication-title: Cytokine doi: 10.1016/j.cyto.2008.12.001 – volume: 69 start-page: 813 year: 2010 end-page: 816 ident: CR40 article-title: Association of CD40 with rheumatoid arthritis confirmed in a large UK case-control study publication-title: Ann. Rheum. Dis. doi: 10.1136/ard.2009.109579 – ident: CR52 – volume: 26 start-page: 229 year: 2014 end-page: 236 ident: CR151 article-title: TWEAK/Fn14 axis: the current paradigm of tissue injury-inducible function in the midst of complexities publication-title: Semin. Immunol. doi: 10.1016/j.smim.2014.02.006 – volume: 94 start-page: 569 year: 2012 end-page: 574 ident: CR225 article-title: Tregs expanded by TNFRSF25 agonists promote cardiac allograft survival publication-title: Transplantation doi: 10.1097/TP.0b013e318264d3ef – volume: 30 start-page: 2815 year: 2000 end-page: 2823 ident: CR55 article-title: Contribution of OX40/OX40 ligand interaction to the pathogenesis of rheumatoid arthritis publication-title: Eur. J. Immunol. doi: 10.1002/1521-4141(200010)30:10<2815::AID-IMMU2815>3.0.CO;2-# – volume: 66 start-page: 228 year: 2007 end-page: 234 ident: CR216 article-title: Selective costimulation modulation using abatacept in patients with active rheumatoid arthritis while receiving etanercept: a randomised clinical trial publication-title: Ann. Rheum. Dis. doi: 10.1136/ard.2006.055111 – volume: 12 start-page: 147 year: 2013 end-page: 168 ident: CR11 article-title: Clinical targeting of the TNF and TNFR superfamilies publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd3930 – volume: 35 start-page: 2359 year: 2008 end-page: 2362 ident: CR72 article-title: Increased serum soluble OX40 in patients with systemic sclerosis publication-title: J. Rheumatol. doi: 10.3899/jrheum.080120 – volume: 272 start-page: 32401 year: 1997 end-page: 32410 ident: CR159 article-title: TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis publication-title: J. Biol. Chem. doi: 10.1074/jbc.272.51.32401 – volume: 79 start-page: 369 year: 2006 end-page: 377 ident: CR199 article-title: Fas costimulation of naive CD4 T cells is controlled by NF-kappaB signaling and caspase activity publication-title: J. Leukoc. Biol. doi: 10.1189/jlb.0505238 – volume: 111 start-page: 2289 year: 2014 end-page: 2294 ident: CR56 article-title: OX40L blockade is therapeutic in arthritis, despite promoting osteoclastogenesis publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1321071111 – volume: 135 start-page: 2109 year: 2015 end-page: 2118 ident: CR144 article-title: The tumor necrosis factor superfamily molecule LIGHT promotes keratinocyte activity and skin fibrosis publication-title: J. Invest. Dermatol. doi: 10.1038/jid.2015.110 – volume: 52 start-page: 623 year: 2013 end-page: 630 ident: CR42 article-title: Association of genetic polymorphisms in CD40 with susceptibility to SLE in the Korean population publication-title: Rheumatology doi: 10.1093/rheumatology/kes339 – volume: 180 start-page: 1059 year: 2012 end-page: 1067 ident: CR101 article-title: Glucocorticoid-induced tumor necrosis factor receptor family-related protein exacerbates collagen-induced arthritis by enhancing the expansion of Th17 cells publication-title: Am. J. Pathol. doi: 10.1016/j.ajpath.2011.11.018 – volume: 316 start-page: 552 year: 1985 end-page: 554 ident: CR1 article-title: Identity of tumour necrosis factor and the macrophage-secreted factor cachectin publication-title: Nature doi: 10.1038/316552a0 – volume: 15 start-page: 353 year: 2004 end-page: 366 ident: CR27 article-title: Ligands working as receptors: reverse signaling by members of the TNF superfamily enhance the plasticity of the immune system publication-title: Cytokine Growth Factor Rev. doi: 10.1016/j.cytogfr.2004.03.011 – volume: 12 start-page: 100 year: 2011 end-page: 109 ident: CR70 article-title: Association of EBF1, FAM167A(C8orf13)-BLK and TNFSF4 gene variants with primary Sjogren's syndrome publication-title: Genes Immun. doi: 10.1038/gene.2010.44 – volume: 47 start-page: 442 year: 2008 end-page: 450 ident: CR160 article-title: Involvement of TWEAK/Fn14 interaction in the synovial inflammation of RA publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/ken006 – volume: 165 start-page: 2089 year: 2012 end-page: 2099 ident: CR99 article-title: Pharmacological modulation of GITRL/GITR system: therapeutic perspectives publication-title: Br. J. Pharmacol. doi: 10.1111/j.1476-5381.2011.01753.x – volume: 188 start-page: 3188 year: 2012 end-page: 3198 ident: CR228 article-title: A novel IL-10-independent regulatory role for B cells in suppressing autoimmunity by maintenance of regulatory T cells via GITR ligand publication-title: J. Immunol. doi: 10.4049/jimmunol.1103354 – volume: 10 start-page: 66 year: 2003 end-page: 75 ident: CR186 article-title: Apo2L/TRAIL and its death and decoy receptors publication-title: Cell Death Differ. doi: 10.1038/sj.cdd.4401187 – volume: 434 start-page: 88 year: 2005 end-page: 93 ident: CR179 article-title: CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death publication-title: Nature doi: 10.1038/nature03337 – volume: 129 start-page: 249 year: 2008 end-page: 255 ident: CR81 article-title: Circulating levels of TNF-like cytokine 1A (TL1A) and its decoy receptor 3 (DcR3) in rheumatoid arthritis publication-title: Clin. Immunol. doi: 10.1016/j.clim.2008.07.014 – volume: 74 start-page: 526 year: 2015 end-page: 531 ident: CR207 article-title: Efficacy and safety of belimumab in primary Sjogren's syndrome: results of the BELISS open-label phase II study publication-title: Ann. Rheum. Dis. doi: 10.1136/annrheumdis-2013-203991 – volume: 28 start-page: 57 year: 2010 end-page: 78 ident: CR54 article-title: Control of immunity by the TNFR-related molecule OX40 (CD134) publication-title: Annu. Rev. Immunol. doi: 10.1146/annurev-immunol-030409-101243 – volume: 181 start-page: 5912 year: 2008 end-page: 5929 ident: CR200 article-title: Fas expression on antigen-specific T cells has costimulatory, helper, and down-regulatory functions for cytotoxic T cell responses but not for T cell-dependent B cell responses publication-title: J. Immunol. doi: 10.4049/jimmunol.181.9.5912 – volume: 136 start-page: 757 year: 2015 end-page: 768 ident: CR149 article-title: Tumor necrosis factor superfamily 14 (LIGHT) controls thymic stromal lymphopoietin to drive pulmonary fibrosis publication-title: J. Allergy Clin. Immunol. doi: 10.1016/j.jaci.2014.12.1936 – volume: 11 start-page: R24 year: 2009 ident: CR146 article-title: Blockade of lymphotoxin-beta receptor signaling reduces aspects of Sjogren's syndrome in salivary glands of non-obese diabetic mice publication-title: Arthritis Res. Ther. doi: 10.1186/ar2617 – volume: 37 start-page: 173 year: 2008 end-page: 178 ident: CR155 article-title: Relationship of serum TWEAK level to cytokine level, disease activity, and response to anti-TNF treatment in patients with rheumatoid arthritis publication-title: Scand. J. Rheumatol. doi: 10.1080/03009740801898608 – volume: 114 start-page: 1603 year: 2004 end-page: 1611 ident: CR57 article-title: TNF-alpha is crucial for the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice publication-title: J. Clin. Invest. doi: 10.1172/JCI20742 – volume: 46 start-page: 513 year: 2016 end-page: 522 ident: CR122 article-title: Deciphering CD137 (4-1BB) signaling in T-cell costimulation for translation into successful cancer immunotherapy publication-title: Eur. J. Immunol. doi: 10.1002/eji.201445388 – volume: 16 start-page: 467 year: 2014 ident: CR136 article-title: Efficacy and safety of pateclizumab (anti-lymphotoxin-alpha) compared to adalimumab in rheumatoid arthritis: a head-to-head phase 2 randomized controlled study (The ALTARA Study) publication-title: Arthritis Res. Ther. doi: 10.1186/s13075-014-0467-3 – volume: 46 start-page: 1063 year: 2007 end-page: 1070 ident: CR143 article-title: The TNF superfamily member LIGHT contributes to survival and activation of synovial fibroblasts in rheumatoid arthritis publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/kem063 – volume: 306 start-page: 927 year: 2014 end-page: 932 ident: CR93 article-title: TNF-like ligand 1A is associated with the pathogenesis of psoriasis vulgaris and contributes to IL-17 production in PBMCs publication-title: Arch. Dermatol. Res. doi: 10.1007/s00403-014-1497-z – volume: 114 start-page: 181 year: 2003 end-page: 190 ident: CR26 article-title: Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes publication-title: Cell doi: 10.1016/S0092-8674(03)00521-X – volume: 11 start-page: 321 year: 2012 end-page: 325 ident: CR217 article-title: Therapeutic blockade of TNF in patients with SLE-promising or crazy? publication-title: Autoimmun. Rev. doi: 10.1016/j.autrev.2011.05.001 – volume: 5 start-page: 439 year: 2004 end-page: 443 ident: CR90 article-title: Death receptor 3 (DR3) gene duplication in a chromosome region 1p36.3: gene duplication is more prevalent in rheumatoid arthritis publication-title: Genes Immun. doi: 10.1038/sj.gene.6364097 – volume: 43 start-page: 175 year: 2014 ident: CR85 article-title: Elevated serum and synovial fluid TNF-like ligand 1A (TL1A) is associated with autoantibody production in patients with rheumatoid arthritis: comments on the article by Sun publication-title: Scand. J. Rheumatol. doi: 10.3109/03009742.2013.848931 – volume: 40 start-page: 579 year: 2013 end-page: 589 ident: CR208 article-title: Efficacy and safety of belimumab in patients with rheumatoid arthritis: a phase II, randomized, double-blind, placebo-controlled, dose-ranging Study publication-title: J. Rheumatol. doi: 10.3899/jrheum.120886 – volume: 53 start-page: 1896 year: 2014 end-page: 1900 ident: CR111 article-title: CD70-expressing CD4 T cells produce IFN-gamma and IL-17 in rheumatoid arthritis publication-title: Rheumatology doi: 10.1093/rheumatology/keu171 – volume: 26 start-page: 183 year: 2014 end-page: 190 ident: CR210 article-title: The TNF family in T cell differentiation and function — unanswered questions and future directions publication-title: Semin. Immunol. doi: 10.1016/j.smim.2014.02.005 – volume: 691 start-page: 279 year: 2011 end-page: 288 ident: CR79 article-title: Insights into TL1A and IBD pathogenesis publication-title: Adv. Exp. Med. Biol. doi: 10.1007/978-1-4419-6612-4_29 – volume: 60 start-page: 2242 year: 2009 end-page: 2247 ident: CR39 article-title: Association of a single-nucleotide polymorphism in CD40 with the rate of joint destruction in rheumatoid arthritis publication-title: Arthritis Rheum. doi: 10.1002/art.24721 – volume: 45 start-page: 523 year: 2008 end-page: 533 ident: CR103 article-title: Reverse signaling initiated from GITRL induces NF-kappaB activation through ERK in the inflammatory activation of macrophages publication-title: Mol. Immunol. doi: 10.1016/j.molimm.2007.05.013 – volume: 179 start-page: 7949 year: 2007 end-page: 7958 ident: CR169 article-title: TWEAK/Fn14 interactions are instrumental in the pathogenesis of nephritis in the chronic graft-versus-host model of systemic lupus erythematosus publication-title: J. Immunol. doi: 10.4049/jimmunol.179.11.7949 – volume: 81 start-page: 935 year: 1995 end-page: 946 ident: CR183 article-title: Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome publication-title: Cell doi: 10.1016/0092-8674(95)90013-6 – volume: 190 start-page: 1076 year: 2013 end-page: 1084 ident: CR220 article-title: TNFR2 is critical for the stabilization of the CD4+Foxp3+ regulatory T. cell phenotype in the inflammatory environment publication-title: J. Immunol. doi: 10.4049/jimmunol.1202659 – volume: 26 start-page: 545 year: 2007 end-page: 547 ident: CR180 article-title: FAScinating receptor in self-tolerance publication-title: Immunity doi: 10.1016/j.immuni.2007.05.004 – ident: CR53 – volume: 8 start-page: R16 year: 2006 ident: CR193 article-title: Intra-articular injection of recombinant TRAIL induces synovial apoptosis and reduces inflammation in a rabbit knee model of arthritis publication-title: Arthritis Res. Ther. doi: 10.1186/ar1867 – volume: 177 start-page: 2610 year: 2006 end-page: 2620 ident: CR163 article-title: TWEAK is a novel arthritogenic mediator publication-title: J. Immunol. doi: 10.4049/jimmunol.177.4.2610 – volume: 16 start-page: 1583 year: 2004 end-page: 1594 ident: CR48 article-title: The contribution of Fc effector mechanisms in the efficacy of anti-CD154 immunotherapy depends on the nature of the immune challenge publication-title: Int. Immunol. doi: 10.1093/intimm/dxh162 – volume: 171 start-page: 2930 year: 2003 end-page: 2936 ident: CR198 article-title: An IL-2-dependent switch between CD95 signaling pathways sensitizes primary human T cells toward CD95-mediated activation-induced cell death publication-title: J. Immunol. doi: 10.4049/jimmunol.171.6.2930 – volume: 34 start-page: 107 year: 2001 end-page: 113 ident: CR212 article-title: Expression of CD40 and CD40 ligand among cell populations within rheumatoid synovial compartment publication-title: Autoimmunity doi: 10.3109/08916930109001958 – volume: 171 start-page: 115 year: 2003 end-page: 126 ident: CR145 article-title: A role for the lymphotoxin/LIGHT axis in the pathogenesis of murine collagen-induced arthritis publication-title: J. Immunol. doi: 10.4049/jimmunol.171.1.115 – volume: 11 start-page: 461 year: 2015 end-page: 470 ident: CR14 article-title: Denosumab for the treatment of osteoporosis publication-title: Expert Opin. Drug Metab. Toxicol. doi: 10.1517/17425255.2015.1000860 – volume: 488 start-page: 222 year: 2012 end-page: 225 ident: CR138 article-title: HVEM signalling at mucosal barriers provides host defence against pathogenic bacteria publication-title: Nature doi: 10.1038/nature11242 – volume: 17 start-page: 35 year: 2010 end-page: 45 ident: CR24 article-title: Regulation of TNFRSF and innate immune signalling complexes by TRAFs and cIAPs publication-title: Cell Death Differ. doi: 10.1038/cdd.2009.114 – volume: 59 start-page: 198 year: 2010 end-page: 203 ident: CR120 article-title: Hypomethylation and overexpression of CD70 (TNFSF7) in CD4+ T cells of patients with primary Sjogren's syndrome publication-title: J. Dermatol. Sci. doi: 10.1016/j.jdermsci.2010.06.011 – volume: 20 start-page: 353 year: 2012 end-page: 366 ident: CR139 article-title: Deletion of a tumor necrosis superfamily gene in mice leads to impaired healing that mimics chronic wounds in humans publication-title: Wound Repair Regen. doi: 10.1111/j.1524-475X.2012.00785.x – volume: 66 start-page: 2762 year: 2014 end-page: 2772 ident: CR89 article-title: Regulation of early cartilage destruction in inflammatory arthritis by death receptor 3 publication-title: Arthritis Rheumatol. doi: 10.1002/art.38770 – volume: 104 start-page: 151 year: 2016 end-page: 155 ident: CR134 article-title: The control of tissue fibrosis by the inflammatory molecule LIGHT (TNF Superfamily member 14) publication-title: Pharmacol. Res. doi: 10.1016/j.phrs.2015.12.018 – volume: 120 start-page: 3629 year: 2010 end-page: 3640 ident: CR224 article-title: Therapeutic Treg expansion in mice by TNFRSF25 prevents allergic lung inflammation publication-title: J. Clin. Invest. doi: 10.1172/JCI42933 – volume: 63 start-page: 3918 year: 2011 end-page: 3930 ident: CR206 article-title: A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus publication-title: Arthritis Rheum. doi: 10.1002/art.30613 – volume: 21 start-page: 293 year: 2009 end-page: 300 ident: CR28 article-title: CD40 and autoimmunity: the dark side of a great activator publication-title: Semin. Immunol. doi: 10.1016/j.smim.2009.05.012 – volume: 156 start-page: 3133 year: 1996 end-page: 3140 ident: CR33 article-title: Cross-linking of the CD40 ligand on human CD4+ T lymphocytes generates a costimulatory signal that up-regulates IL-4 synthesis publication-title: J. Immunol. – volume: 8 start-page: 1405 year: 2002 end-page: 1413 ident: CR128 article-title: Costimulatory molecule-targeted antibody therapy of a spontaneous autoimmune disease publication-title: Nat. Med. doi: 10.1038/nm1202-796 – volume: 223 start-page: 202 year: 2008 end-page: 220 ident: CR131 article-title: Inhibition of the lymphotoxin pathway as a therapy for autoimmune disease publication-title: Immunol. Rev. doi: 10.1111/j.1600-065X.2008.00633.x – volume: 5 start-page: e1000528 year: 2009 ident: CR91 article-title: Comprehensive linkage and association analyses identify haplotype, near to the TNFSF15 gene, significantly associated with spondyloarthritis publication-title: PLoS Genet. doi: 10.1371/journal.pgen.1000528 – volume: 66 start-page: 836 year: 2014 end-page: 844 ident: CR8 article-title: TNF inhibitors — mechanisms of action, approved and off-label indications publication-title: Pharmacol. Rep. doi: 10.1016/j.pharep.2014.05.004 – volume: 81 start-page: 239 year: 1996 end-page: 243 ident: CR114 article-title: Elevated soluble CD27 levels in serum of patients with systemic lupus erythematosus publication-title: Clin. Immunol. Immunopathol. doi: 10.1006/clin.1996.0184 – volume: 20 start-page: 725 year: 2011 end-page: 731 ident: CR92 article-title: Upregulation and nuclear localization of TNF-like cytokine 1A (TL1A) and its receptors DR3 and DcR3 in psoriatic skin lesions publication-title: Exp. Dermatol. doi: 10.1111/j.1600-0625.2011.01304.x – volume: 80 start-page: 129 year: 1996 end-page: 138 ident: CR109 article-title: Expression of the activation antigen CD27 in rheumatoid arthritis publication-title: Clin. Immunol. Immunopathol. doi: 10.1006/clin.1996.0106 – volume: 98 start-page: 333 year: 2015 end-page: 345 ident: CR78 article-title: The TNF-family cytokine TL1A: from lymphocyte costimulator to disease co-conspirator publication-title: J. Leukoc. Biol. doi: 10.1189/jlb.3RI0315-095R – volume: 51 start-page: 47 year: 2012 end-page: 51 ident: CR41 article-title: CD40 gene polymorphisms confer risk of Behcet's disease but not of Vogt-Koyanagi-Harada syndrome in a Han Chinese population publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/ker345 – volume: 11 start-page: R16 year: 2009 ident: CR189 article-title: Susceptibility of rheumatoid arthritis synovial fibroblasts to FasL- and TRAIL-induced apoptosis is cell cycle-dependent publication-title: Arthritis Res. Ther. doi: 10.1186/ar2607 – volume: 9 start-page: 705 year: 2013 end-page: 720 ident: CR218 article-title: Future prospects in biologic therapy for systemic lupus erythematosus publication-title: Nat. Rev. Rheumatol. doi: 10.1038/nrrheum.2013.136 – volume: 176 start-page: 1889 year: 2006 end-page: 1898 ident: CR173 article-title: Proinflammatory effects of TWEAK/Fn14 interactions in glomerular mesangial cells publication-title: J. Immunol. doi: 10.4049/jimmunol.176.3.1889 – volume: 8 start-page: 76 year: 2016 ident: CR22 article-title: Targeted genomic analysis reveals widespread autoimmune disease association with variants that regulate gene expression in the TNF superfamily cytokine signalling network publication-title: Genome Med. doi: 10.1186/s13073-016-0329-5 – volume: 205 start-page: 1037 year: 2008 end-page: 1048 ident: CR76 article-title: Essential role of TNF receptor superfamily 25 (TNFRSF25) in the development of allergic lung inflammation publication-title: J. Exp. Med. doi: 10.1084/jem.20072528 – volume: 145 start-page: 226 year: 1994 end-page: 234 ident: CR31 article-title: CD40-mediated regulation of human B-cell responses publication-title: Res. Immunol. doi: 10.1016/S0923-2494(94)80189-4 – volume: 112 start-page: 1332 year: 2003 end-page: 1341 ident: CR192 article-title: CII-DC-AdTRAIL cell gene therapy inhibits infiltration of CII-reactive T cells and CII-induced arthritis publication-title: J. Clin. Invest. doi: 10.1172/JCI200319209 – ident: CR19 – volume: 42 start-page: 1393 year: 2012 end-page: 1404 ident: CR230 article-title: Enhanced GITR/GITRL interactions augment IL-27 expression and induce IL-10-producing Tr-1 like cells publication-title: Eur. J. Immunol. doi: 10.1002/eji.201142162 – volume: 23 start-page: S8 issue: Suppl. 1 year: 2015 end-page: S17 ident: CR18 article-title: A systematic review of the efficacy and general safety of antibodies to NGF in the treatment of OA of the hip or knee publication-title: Osteoarthritis Cartilage doi: 10.1016/j.joca.2014.10.003 – volume: 261 start-page: 1328 year: 1993 end-page: 1330 ident: CR34 article-title: Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40 publication-title: Science doi: 10.1126/science.7689748 – volume: 122 start-page: 394 year: 2007 end-page: 400 ident: CR127 article-title: Role of endogenous 4-1BB in the development of systemic lupus erythematosus publication-title: Immunology doi: 10.1111/j.1365-2567.2007.02653.x – volume: 29 start-page: 79 year: 2008 end-page: 89 ident: CR74 article-title: The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases publication-title: Immunity doi: 10.1016/j.immuni.2008.04.021 – volume: 66 start-page: 2728 year: 2014 end-page: 2738 ident: CR221 article-title: Selective tumor necrosis factor receptor I blockade is antiinflammatory and reveals immunoregulatory role of tumor necrosis factor receptor II in collagen-induced arthritis publication-title: Arthritis Rheumatol. doi: 10.1002/art.38755 – volume: 16 start-page: 474 year: 2014 ident: CR69 article-title: Soluble OX40L is associated with presence of autoantibodies in early rheumatoid arthritis publication-title: Arthritis Res. Ther. doi: 10.1186/s13075-014-0474-4 – volume: 69 start-page: 305 year: 2010 end-page: 308 ident: CR115 article-title: HLA-DRhigh/CD27high plasmablasts indicate active disease in patients with systemic lupus erythematosus publication-title: Ann. Rheum. Dis. doi: 10.1136/ard.2008.096495 – volume: 104 start-page: 487 year: 2001 end-page: 501 ident: CR3 article-title: The TNF and TNF receptor superfamilies: integrating mammalian biology publication-title: Cell doi: 10.1016/S0092-8674(01)00237-9 – volume: 31 start-page: 29 year: 2011 end-page: 34 ident: CR65 article-title: OX40/OX40L in systemic lupus erythematosus: association with disease activity and lupus nephritis publication-title: Ann. Saudi Med. doi: 10.4103/0256-4947.75775 – volume: 244 start-page: 99 year: 2011 end-page: 114 ident: CR152 article-title: TWEAK/Fn14 pathway: an immunological switch for shaping tissue responses publication-title: Immunol. Rev. doi: 10.1111/j.1600-065X.2011.01054.x – volume: 12 start-page: 205 year: 2016 end-page: 216 ident: CR214 article-title: Hurdles to the introduction of new therapies for immune-mediated kidney diseases publication-title: Nat. Rev. Nephrol. doi: 10.1038/nrneph.2015.206 – volume: 28 start-page: 95 year: 2001 end-page: 101 ident: CR46 article-title: Phase I clinical trial of a monoclonal antibody against CD40-ligand (IDEC-131) in patients with systemic lupus erythematosus publication-title: J. Rheumatol. – volume: 43 start-page: 44 year: 2013 end-page: 54 ident: CR170 article-title: Neuropsychiatric disease in murine lupus is dependent on the TWEAK/Fn14 pathway publication-title: J. Autoimmun. doi: 10.1016/j.jaut.2013.03.002 – volume: 7 start-page: 1492 year: 2014 end-page: 1503 ident: CR213 article-title: Inhibition of a novel fibrogenic factor Tl1a reverses established colonic fibrosis publication-title: Mucosal Immunol. doi: 10.1038/mi.2014.37 – volume: 18 start-page: 712 year: 2011 end-page: 720 ident: CR178 article-title: Specific elimination of effector memory CD4+ T cells due to enhanced Fas signaling complex formation and association with lipid raft microdomains publication-title: Cell Death Differ. doi: 10.1038/cdd.2010.155 – volume: 18 start-page: 473 year: 2014 end-page: 489 ident: CR10 article-title: Therapeutic targeting of the BAFF/APRIL axis in systemic lupus erythematosus publication-title: Expert Opin. Ther. Targets doi: 10.1517/14728222.2014.888415 – volume: 50 start-page: 150 year: 2012 end-page: 159 ident: CR196 article-title: CTLA4-FasL fusion product suppresses proliferation of fibroblast-like synoviocytes and progression of adjuvant-induced arthritis in rats publication-title: Mol. Immunol. doi: 10.1016/j.molimm.2012.01.007 – volume: 19 start-page: 317 year: 2001 end-page: 320 ident: CR58 article-title: T lymphocytes in the synovial fluid of patients with active rheumatoid arthritis display CD134-OX40 surface antigen publication-title: Clin. Exp. Rheumatol. – volume: 15 start-page: 837 year: 2001 end-page: 846 ident: CR153 article-title: A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis publication-title: Immunity doi: 10.1016/S1074-7613(01)00232-1 – volume: 179 start-page: 2609 year: 2007 end-page: 2615 ident: CR110 article-title: Unchecked CD70 expression on T cells lowers threshold for T cell activation in rheumatoid arthritis publication-title: J. Immunol. doi: 10.4049/jimmunol.179.4.2609 – volume: 1832 start-page: 1744 year: 2013 end-page: 1755 ident: CR162 article-title: TNF-related weak inducer of apoptosis (TWEAK) promotes kidney fibrosis and Ras-dependent proliferation of cultured renal fibroblast publication-title: Biochim. Biophys. Acta doi: 10.1016/j.bbadis.2013.05.032 – volume: 364 start-page: 806 year: 1993 end-page: 809 ident: CR197 article-title: Lethal effect of the anti-Fas antibody in mice publication-title: Nature doi: 10.1038/364806a0 – volume: 647 start-page: 8 year: 2009 end-page: 36 ident: CR29 article-title: Therapeutic interventions targeting CD40L (CD154) and CD40: the opportunities and challenges publication-title: Adv. Exp. Med. Biol. doi: 10.1007/978-0-387-89520-8_2 – volume: 268 start-page: 1347 year: 1995 end-page: 1349 ident: CR182 article-title: Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity publication-title: Science doi: 10.1126/science.7539157 – volume: 24 start-page: 1177 year: 2015 end-page: 1183 ident: CR44 article-title: Associations between the functional CD40 rs4810485 G/T polymorphism and susceptibility to rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis publication-title: Lupus doi: 10.1177/0961203315583543 – volume: 37 start-page: 342 year: 2011 end-page: 351 ident: CR227 article-title: Antigen-specific prevention of type 1 diabetes in NOD mice is ameliorated by OX40 agonist treatment publication-title: J. Autoimmun. doi: 10.1016/j.jaut.2011.10.001 – volume: 157 start-page: 3159 year: 1996 end-page: 3164 ident: CR36 article-title: Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand black x New Zealand white mice. Response correlates with the absence of an anti-antibody response publication-title: J. Immunol. – volume: 175 start-page: 1295 year: 2005 end-page: 1300 ident: CR140 article-title: Contribution of the lymphotoxin beta receptor to liver regeneration publication-title: J. Immunol. doi: 10.4049/jimmunol.175.2.1295 – volume: 23 start-page: 23 year: 2005 end-page: 68 ident: CR209 article-title: TNF/TNFR family members in costimulation of T cell responses publication-title: Annu. Rev. Immunol. doi: 10.1146/annurev.immunol.23.021704.115839 – volume: 196 start-page: 2145 year: 2016 end-page: 2152 ident: CR229 article-title: Ptpn22 modifies regulatory T cell homeostasis via GITR upregulation publication-title: J. Immunol. doi: 10.4049/jimmunol.1501877 – volume: 42 start-page: 97 year: 2013 end-page: 101 ident: CR84 article-title: Elevated serum and synovial fluid TNF-like ligand 1A (TL1A) is associated with autoantibody production in patients with rheumatoid arthritis publication-title: Scand. J. Rheumatol. doi: 10.3109/03009742.2012.727026 – volume: 274 start-page: 33166 year: 1999 end-page: 33176 ident: CR154 article-title: The mitogen-inducible Fn14 gene encodes a type I transmembrane protein that modulates fibroblast adhesion and migration publication-title: J. Biol. Chem. doi: 10.1074/jbc.274.46.33166 – ident: CR176 – volume: 3 start-page: 609 year: 2003 end-page: 620 ident: CR4 article-title: Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? publication-title: Nat. Rev. Immunol. doi: 10.1038/nri1148 – volume: 987 start-page: 230 year: 2003 end-page: 235 ident: CR129 article-title: CD137-mediated T cell co-stimulation terminates existing autoimmune disease in SLE-prone NZB/NZW F1 mice publication-title: Ann. NY Acad. Sci. doi: 10.1111/j.1749-6632.2003.tb06052.x – volume: 35 start-page: 3581 year: 2005 end-page: 3590 ident: CR104 article-title: Glucocorticoid-induced TNFR family-related protein (GITR) activation exacerbates murine asthma and collagen-induced arthritis publication-title: Eur. J. Immunol. doi: 10.1002/eji.200535421 – volume: 647 start-page: 146 year: 2009 end-page: 155 ident: CR132 article-title: Targeting the LIGHT-HVEM pathway publication-title: Adv. Exp. Med. Biol. doi: 10.1007/978-0-387-89520-8_10 – volume: 143 start-page: 39 year: 2012 end-page: 44 ident: CR119 article-title: Demethylation of TNFSF7 contributes to CD70 overexpression in CD4+ T cells from patients with systemic sclerosis publication-title: Clin. Immunol. doi: 10.1016/j.clim.2012.01.005 – volume: 191 start-page: 5420 year: 2013 end-page: 5429 ident: CR88 article-title: TNF-like ligand 1A (TL1A) gene knockout leads to ameliorated collagen-induced arthritis in mice: implication of TL1A in humoral immune responses publication-title: J. Immunol. doi: 10.4049/jimmunol.1301475 – volume: 40 start-page: 83 year: 2008 end-page: 89 ident: CR66 article-title: Polymorphism at the TNF superfamily gene TNFSF4 confers susceptibility to systemic lupus erythematosus publication-title: Nat. Genet. doi: 10.1038/ng.2007.47 – volume: 69 start-page: 550 year: 2010 end-page: 555 ident: CR71 article-title: Association of TNFSF4 (OX40L) polymorphisms with susceptibility to systemic sclerosis publication-title: Ann. Rheum. Dis. doi: 10.1136/ard.2009.116434 – volume: 19 start-page: 953 year: 2008 end-page: 960 ident: CR96 article-title: TL1A both promotes and protects from renal inflammation and injury publication-title: J. Am. Soc. Nephrol. doi: 10.1681/ASN.2007060706 – volume: 12 start-page: R33 year: 2010 ident: CR190 article-title: Akt activity protects rheumatoid synovial fibroblasts from Fas-induced apoptosis by inhibition of Bid cleavage publication-title: Arthritis Res. Ther. doi: 10.1186/ar2941 – volume: 183 start-page: 857 year: 2013 end-page: 867 ident: CR165 article-title: TWEAK promotes osteoclastogenesis in rheumatoid arthritis publication-title: Am. J. Pathol. doi: 10.1016/j.ajpath.2013.05.027 – volume: 259 start-page: 990 year: 1993 end-page: 993 ident: CR30 article-title: CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome publication-title: Science doi: 10.1126/science.7679801 – volume: 13 start-page: R51 year: 2011 ident: CR157 article-title: TWEAK and Fn14 expression in the pathogenesis of joint inflammation and bone erosion in rheumatoid arthritis publication-title: Arthritis Res. Ther. doi: 10.1186/ar3294 – volume: 2012 start-page: 265868 year: 2012 ident: CR105 article-title: Correlation of circulating glucocorticoid-induced TNFR-related protein ligand levels with disease activity in patients with systemic lupus erythematosus publication-title: Clin. Dev. Immunol. doi: 10.1155/2012/265868 – volume: 169 start-page: 4628 year: 2002 end-page: 4636 ident: CR68 article-title: Constitutive OX40/OX40 ligand interaction induces autoimmune-like diseases publication-title: J. Immunol. doi: 10.4049/jimmunol.169.8.4628 – volume: 30 start-page: 4126 year: 1998 end-page: 4127 ident: CR2 article-title: Anti-TNF alpha therapy is useful in rheumatoid arthritis and Crohn's disease: analysis of the mechanism of action predicts utility in other diseases publication-title: Transplant. Proc. doi: 10.1016/S0041-1345(98)01365-7 – volume: 171 start-page: 1061 year: 2003 end-page: 1069 ident: CR188 article-title: TRAIL-R2 (DR5) mediates apoptosis of synovial fibroblasts in rheumatoid arthritis publication-title: J. Immunol. doi: 10.4049/jimmunol.171.2.1061 – volume: 37 start-page: 1407 year: 2007 end-page: 1413 ident: CR117 article-title: Defective DNA methylation and CD70 overexpression in CD4+ T cells in MRL/lpr lupus-prone mice publication-title: Eur. J. Immunol. doi: 10.1002/eji.200636872 – volume: 335 start-page: 1643 year: 1996 end-page: 1649 ident: CR184 article-title: Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity publication-title: N. Engl. J. Med. doi: 10.1056/NEJM199611283352204 – volume: 37 start-page: 204 year: 2010 end-page: 205 ident: CR219 article-title: Induction of systemic lupus erythematosus with tumor necrosis factor blockers publication-title: J. Rheumatol. doi: 10.3899/jrheum.081312 – volume: 177 start-page: 6433 year: 2006 end-page: 6439 ident: CR164 article-title: Involvement of TNF-like weak inducer of apoptosis in the pathogenesis of collagen-induced arthritis publication-title: J. Immunol. doi: 10.4049/jimmunol.177.9.6433 – volume: 9 start-page: 271 year: 2009 end-page: 285 ident: CR5 article-title: The role of TNF superfamily members in T-cell function and diseases publication-title: Nat. Rev. Immunol. doi: 10.1038/nri2526 – volume: 34 start-page: 51 year: 2014 end-page: 57 ident: CR195 article-title: Anti-arthritic effects of FasL gene transferred intra-articularly by an inducible lentiviral vector containing improved tet-on system publication-title: Rheumatol. Int. doi: 10.1007/s00296-011-2002-z – volume: 12 start-page: R150 year: 2010 ident: CR64 article-title: Increased expression of costimulatory markers CD134 and CD80 on interleukin-17 producing T cells in patients with systemic lupus erythematosus publication-title: Arthritis Res. Ther. doi: 10.1186/ar3100 – volume: 145 start-page: 108 year: 2012 end-page: 121 ident: CR168 article-title: Inhibition of the TWEAK/Fn14 pathway attenuates renal disease in nephrotoxic serum nephritis publication-title: Clin. Immunol. doi: 10.1016/j.clim.2012.08.008 – volume: 27 start-page: 55 year: 2015 end-page: 62 ident: CR204 article-title: Anti-TNF therapy: past, present and future publication-title: Int. Immunol. doi: 10.1093/intimm/dxu102 – volume: 35 start-page: 1435 year: 2015 end-page: 1437 ident: CR94 article-title: Elevated plasma levels of TL1A in newly diagnosed systemic lupus erythematosus patients publication-title: Rheumatol. Int. doi: 10.1007/s00296-015-3277-2 – volume: 11 start-page: 1426 year: 2000 end-page: 1438 ident: CR60 article-title: Strong and selective glomerular localization of CD134 ligand and TNF receptor-1 in proliferative lupus nephritis publication-title: J. Am. Soc. Nephrol. doi: 10.1681/ASN.V1181426 – volume: 290 start-page: 209 year: 2014 end-page: 216 ident: CR203 article-title: Effect of CD95 on inflammatory response in rheumatoid arthritis fibroblast-like synoviocytes publication-title: Cell. Immunol. doi: 10.1016/j.cellimm.2014.07.004 – volume: 33 start-page: 2792 year: 2003 end-page: 2800 ident: CR211 article-title: Increased CD40 expression in skin fibroblasts from patients with systemic sclerosis (SSc): role of CD40-CD154 in the phenotype of SSc fibroblasts publication-title: Eur. J. Immunol. doi: 10.1002/eji.200324088 – volume: 36 start-page: 13 year: 2004 end-page: 22 ident: CR124 article-title: Serum concentrations of soluble 4-1BB and 4-1BB ligand correlated with the disease severity in rheumatoid arthritis publication-title: Exp. Mol. Med. doi: 10.1038/emm.2004.2 – volume: 17 start-page: 234 year: 2015 ident: CR50 article-title: CDP7657, an anti-CD40L antibody lacking an Fc domain, inhibits CD40L-dependent immune responses without thrombotic complications: an study publication-title: Arthritis Res. Ther. doi: 10.1186/s13075-015-0757-4 – volume: 53 start-page: 289 year: 2011 end-page: 291 ident: CR158 article-title: Increased serum TWEAK levels in psoriatic arthritis: relationship with disease activity and matrix metalloproteinase-3 serum levels publication-title: Cytokine doi: 10.1016/j.cyto.2010.12.003 – volume: 244 start-page: 188 year: 2011 end-page: 196 ident: CR77 article-title: TL1A and DR3, a TNF family ligand-receptor pair that promotes lymphocyte costimulation, mucosal hyperplasia, and autoimmune inflammation publication-title: Immunol. Rev. doi: 10.1111/j.1600-065X.2011.01068.x – volume: 163 start-page: 401 year: 2003 end-page: 411 ident: CR95 article-title: Expression of silencer of death domains and death-receptor-3 in normal human kidney and in rejecting renal transplants publication-title: Am. J. Pathol. doi: 10.1016/S0002-9440(10)63670-X – volume: 229 start-page: 216 year: 2009 end-page: 231 ident: CR107 article-title: Timing and tuning of CD27-CD70 interactions: the impact of signal strength in setting the balance between adaptive responses and immunopathology publication-title: Immunol. Rev. doi: 10.1111/j.1600-065X.2009.00774.x – volume: 54 start-page: 1451 year: 2006 end-page: 1462 ident: CR142 article-title: LIGHT (TNFSF14), a novel mediator of bone resorption, is elevated in rheumatoid arthritis publication-title: Arthritis Rheum. doi: 10.1002/art.21821 – volume: 66 start-page: 3289 year: 2014 end-page: 3299 ident: CR202 article-title: Distinct effects of soluble and membrane-bound fas ligand on fibroblast-like synoviocytes from rheumatoid arthritis patients publication-title: Arthritis Rheumatol. doi: 10.1002/art.38806 – volume: 33 start-page: 144 year: 2012 end-page: 152 ident: CR6 article-title: TNF superfamily in inflammatory disease: translating basic insights publication-title: Trends Immunol. doi: 10.1016/j.it.2011.10.004 – volume: 3 start-page: 642 year: 2003 end-page: 655 ident: CR137 article-title: Lymphotoxin/light, lymphoid microenvironments and autoimmune disease publication-title: Nat. Rev. Immunol. doi: 10.1038/nri1151 – volume: 72 start-page: 185 year: 2015 end-page: 189 ident: CR86 article-title: Serum and synovial fluid levels of tumor necrosis factor-like ligand 1A and decoy receptor 3 in rheumatoid arthritis publication-title: Cytokine doi: 10.1016/j.cyto.2014.12.026 – volume: 2010 start-page: 239083 year: 2010 ident: CR98 article-title: Glucocorticoid-induced TNFR-related (GITR) protein and its ligand in antitumor immunity: functional role and therapeutic modulation publication-title: Clin. Dev. Immunol. doi: 10.1155/2010/239083 – volume: 50 start-page: 1412 year: 2004 end-page: 1419 ident: CR215 article-title: Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate publication-title: Arthritis Rheum. doi: 10.1002/art.20221 – volume: 332 start-page: 858 year: 2010 end-page: 865 ident: CR194 article-title: Effect of tumor necrosis factor-related apoptosis-inducing ligand on the reduction of joint inflammation in experimental rheumatoid arthritis publication-title: J. Pharmacol. Exp. Ther. doi: 10.1124/jpet.109.159517 – volume: 183 start-page: 5350 year: 2009 end-page: 5357 ident: CR82 article-title: Role of TL1A in the pathogenesis of rheumatoid arthritis publication-title: J. Immunol. doi: 10.4049/jimmunol.0802645 – volume: 48 start-page: 719 year: 2003 end-page: 727 ident: CR45 article-title: A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis publication-title: Arthritis Rheum. doi: 10.1002/art.10856 – volume: 228 start-page: 225 year: 2009 end-page: 240 ident: CR25 article-title: TNFR signaling: ubiquitin-conjugated TRAFfic signals control stop-and-go for MAPK signaling complexes publication-title: Immunol. Rev. doi: 10.1111/j.1600-065X.2008.00755.x – volume: 10 start-page: 335 year: 2011 end-page: 336 ident: CR205 article-title: Belimumab publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd3436 – volume: 24 start-page: 161 year: 2009 end-page: 171 ident: CR73 article-title: CD4+CD25+ T-cell populations expressing CD134 and GITR are associated with disease activity in patients with Wegener's granulomatosis publication-title: Nephrol. Dial. Transplant. doi: 10.1093/ndt/gfn461 – volume: 89 start-page: 113 year: 2016 end-page: 126 ident: CR148 article-title: The lymphotoxin beta receptor is a potential therapeutic target in renal inflammation publication-title: Kidney Int. doi: 10.1038/ki.2015.280 – volume: 98 start-page: 47 year: 1999 end-page: 58 ident: CR187 article-title: Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II publication-title: Cell doi: 10.1016/S0092-8674(00)80605-4 – volume: 113 start-page: 89 year: 2004 end-page: 98 ident: CR126 article-title: Engagement of the CD137 (4-1BB) costimulatory molecule inhibits and reverses the autoimmune process in collagen-induced arthritis and establishes lasting disease resistance publication-title: Immunology doi: 10.1111/j.1365-2567.2004.01952.x – volume: 46 start-page: 3251 year: 2002 end-page: 3258 ident: CR47 article-title: Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti-CD154: a randomized, double-blind, placebo-controlled trial publication-title: Arthritis Rheum. doi: 10.1002/art.10681 – volume: 35 start-page: 1137 year: 2013 end-page: 1149 ident: CR166 article-title: Safety, tolerability, pharmacokinetics, and pharmacodynamics of anti-TWEAK monoclonal antibody in patients with rheumatoid arthritis publication-title: Clin. Ther. doi: 10.1016/j.clinthera.2013.06.008 – volume: 42 start-page: 403 year: 2012 end-page: 412 ident: CR222 article-title: TNFR2 on non-haematopoietic cells is required for Foxp3+ Treg-cell function and disease suppression in EAE publication-title: Eur. J. Immunol. doi: 10.1002/eji.201141659 – volume: 15 start-page: 135 year: 2008 end-page: 143 ident: CR63 article-title: Flowcytometric study of expression of perforin and CD134 in patients with systemic lupus erythematosus publication-title: Egypt. J. Immunol. – volume: 19 start-page: 695 year: 2008 end-page: 703 ident: CR167 article-title: The cytokine TWEAK modulates renal tubulointerstitial inflammation publication-title: J. Am. Soc. Nephrol. doi: 10.1681/ASN.2007050577 – volume: 42 start-page: 1159 year: 2015 end-page: 1170 ident: CR61 article-title: OX40 ligand contributes to human lupus pathogenesis by promoting T follicular helper response publication-title: Immunity doi: 10.1016/j.immuni.2015.05.012 – volume: 195 start-page: 2429 year: 2015 end-page: 2441 ident: CR141 article-title: The TNF family molecules LIGHT and lymphotoxin alphabeta induce a distinct steroid-resistant inflammatory phenotype in human lung epithelial cells publication-title: J. Immunol. doi: 10.4049/jimmunol.1500356 – volume: 15 start-page: 2825 year: 2015 end-page: 2836 ident: CR51 article-title: A novel, blocking, Fc-silent anti-CD40 monoclonal antibody prolongs nonhuman primate renal allograft survival in the absence of B cell depletion publication-title: Am. J. Transplant. doi: 10.1111/ajt.13377 – volume: 39 start-page: 1552 year: 2009 end-page: 1563 ident: CR223 article-title: Origins and functional basis of regulatory CD11c+CD8+ T cells publication-title: Eur. J. Immunol. doi: 10.1002/eji.200839057 – volume: 71 start-page: 1134 year: 2012 end-page: 1142 ident: CR135 article-title: A comparative effectiveness study of adalimumab, etanercept and infliximab in biologically naive and switched rheumatoid arthritis patients: results from the US CORRONA registry publication-title: Ann. Rheum. Dis. doi: 10.1136/annrheumdis-2011-150573 – volume: 205 start-page: 1049 year: 2008 end-page: 1062 ident: CR75 article-title: TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease publication-title: J. Exp. Med. doi: 10.1084/jem.20071364 – volume: 153 start-page: 85 year: 1996 end-page: 106 ident: CR32 article-title: The role of CD40 ligand in costimulation and T-cell activation publication-title: Immunol. Rev. doi: 10.1111/j.1600-065X.1996.tb00921.x – volume: 244 start-page: 197 year: 2011 end-page: 217 ident: CR121 article-title: T-Cell intrinsic effects of GITR and 4-1BB during viral infection and cancer immunotherapy publication-title: Immunol. Rev. doi: 10.1111/j.1600-065X.2011.01063.x – volume: 12 start-page: 49 year: 2016 end-page: 62 ident: CR7 article-title: TNF biology, pathogenic mechanisms and emerging therapeutic strategies publication-title: Nat. Rev. Rheumatol. doi: 10.1038/nrrheum.2015.169 – volume: 22 start-page: 54 year: 2011 end-page: 59 ident: CR67 article-title: Increased OX40 and soluble OX40 ligands in children with Henoch-Schonlein purpura: association with renal involvement publication-title: Pediatr. Allergy Immunol. doi: 10.1111/j.1399-3038.2010.01111.x – volume: 205 start-page: 2457 year: 2008 end-page: 2464 ident: CR87 article-title: The death receptor 3-TNF-like protein 1A pathway drives adverse bone pathology in inflammatory arthritis publication-title: J. Exp. Med. doi: 10.1084/jem.20072378 – volume: 5 start-page: 511 year: 2014 ident: CR9 article-title: Biology of the RANKL-RANK-OPG system in immunity, bone, and beyond publication-title: Front. Immunol. doi: 10.3389/fimmu.2014.00511 – volume: 11 start-page: e0157105 year: 2016 ident: CR20 article-title: Tanezumab for patients with osteoarthritis of the knee: a meta-analysis publication-title: PLoS ONE doi: 10.1371/journal.pone.0157105 – volume: 5 start-page: 50 year: 2014 ident: CR161 article-title: TWEAK-Fn14 cytokine-receptor axis: a new player of myocardial remodeling and cardiac failure publication-title: Front. Immunol. doi: 10.3389/fimmu.2014.00050 – volume: 14 start-page: 293 year: 1995 end-page: 300 ident: CR113 article-title: Serum levels of soluble forms of T cell activation antigens CD27 and CD25 in systemic lupus erythematosus in relation with lymphocytes count and disease course publication-title: Clin. Rheumatol. doi: 10.1007/BF02208342 – volume: 10 start-page: 365 year: 2014 end-page: 373 ident: CR17 article-title: The BAFF/APRIL system in SLE pathogenesis publication-title: Nat. Rev. Rheumatol. doi: 10.1038/nrrheum.2014.33 – volume: 63 start-page: 310 year: 2004 end-page: 317 ident: CR37 article-title: The dinucleotide repeat polymorphism in the 3′UTR of the CD154 gene has a functional role on protein expression and is associated with systemic lupus erythematosus publication-title: Ann. Rheum. Dis. doi: 10.1136/ard.2003.006148 – volume: 61 start-page: 534 year: 2015 end-page: 542 ident: CR15 article-title: The RANKL-RANK story publication-title: Gerontology doi: 10.1159/000371845 – volume: 147 start-page: 144 year: 2013 end-page: 150 ident: CR83 article-title: Circulating levels of TNF-like cytokine 1A correlate with the progression of atheromatous lesions in patients with rheumatoid arthritis publication-title: Clin. Immunol. doi: 10.1016/j.clim.2013.03.002 – volume: 50 start-page: 1850 year: 2004 end-page: 1860 ident: CR116 article-title: Overexpression of CD70 and overstimulation of IgG synthesis by lupus T cells and T cells treated with DNA methylation inhibitors publication-title: Arthritis Rheum. doi: 10.1002/art.20255 – volume: 2013 start-page: 340751 year: 2013 ident: CR106 article-title: Correlation of increased blood levels of GITR and GITRL with disease severity in patients with primary Sjogren's syndrome publication-title: Clin. Dev. Immunol. doi: 10.1155/2013/340751 – volume: 19 start-page: 1253 year: 2005 end-page: 1265 ident: CR100 article-title: Role of glucocorticoid-induced TNF receptor family gene (GITR) in collagen-induced arthritis publication-title: FASEB J. doi: 10.1096/fj.04-3556com – volume: 244 start-page: 188 year: 2011 ident: BFnrrheum201722_CR77 publication-title: Immunol. Rev. doi: 10.1111/j.1600-065X.2011.01068.x – volume: 63 start-page: 310 year: 2004 ident: BFnrrheum201722_CR37 publication-title: Ann. Rheum. Dis. doi: 10.1136/ard.2003.006148 – volume: 145 start-page: 108 year: 2012 ident: BFnrrheum201722_CR168 publication-title: Clin. Immunol. doi: 10.1016/j.clim.2012.08.008 – volume: 306 start-page: 927 year: 2014 ident: BFnrrheum201722_CR93 publication-title: Arch. Dermatol. Res. doi: 10.1007/s00403-014-1497-z – volume: 122 start-page: 394 year: 2007 ident: BFnrrheum201722_CR127 publication-title: Immunology doi: 10.1111/j.1365-2567.2007.02653.x – volume: 16 start-page: 1583 year: 2004 ident: BFnrrheum201722_CR48 publication-title: Int. Immunol. doi: 10.1093/intimm/dxh162 – volume: 171 start-page: 2930 year: 2003 ident: BFnrrheum201722_CR198 publication-title: J. Immunol. doi: 10.4049/jimmunol.171.6.2930 – volume: 98 start-page: 333 year: 2015 ident: BFnrrheum201722_CR78 publication-title: J. Leukoc. Biol. doi: 10.1189/jlb.3RI0315-095R – volume: 220 start-page: 497 year: 2014 ident: BFnrrheum201722_CR21 publication-title: Handb. Exp. Pharmacol. doi: 10.1007/978-3-642-45106-5_19 – volume: 5 start-page: e1000528 year: 2009 ident: BFnrrheum201722_CR91 publication-title: PLoS Genet. doi: 10.1371/journal.pgen.1000528 – volume: 5 start-page: 439 year: 2004 ident: BFnrrheum201722_CR90 publication-title: Genes Immun. doi: 10.1038/sj.gene.6364097 – volume: 5 start-page: 50 year: 2014 ident: BFnrrheum201722_CR161 publication-title: Front. Immunol. doi: 10.3389/fimmu.2014.00050 – volume: 183 start-page: 857 year: 2013 ident: BFnrrheum201722_CR165 publication-title: Am. J. Pathol. doi: 10.1016/j.ajpath.2013.05.027 – volume: 30 start-page: 2815 year: 2000 ident: BFnrrheum201722_CR55 publication-title: Eur. J. Immunol. doi: 10.1002/1521-4141(200010)30:10<2815::AID-IMMU2815>3.0.CO;2-# – volume: 8 start-page: R16 year: 2006 ident: BFnrrheum201722_CR193 publication-title: Arthritis Res. Ther. doi: 10.1186/ar1867 – volume: 63 start-page: 3918 year: 2011 ident: BFnrrheum201722_CR206 publication-title: Arthritis Rheum. doi: 10.1002/art.30613 – volume: 23 start-page: S8 issue: Suppl. 1 year: 2015 ident: BFnrrheum201722_CR18 publication-title: Osteoarthritis Cartilage doi: 10.1016/j.joca.2014.10.003 – volume: 691 start-page: 383 year: 2011 ident: BFnrrheum201722_CR147 publication-title: Adv. Exp. Med. Biol. doi: 10.1007/978-1-4419-6612-4_39 – volume: 274 start-page: 33166 year: 1999 ident: BFnrrheum201722_CR154 publication-title: J. Biol. Chem. doi: 10.1074/jbc.274.46.33166 – volume: 143 start-page: 39 year: 2012 ident: BFnrrheum201722_CR119 publication-title: Clin. Immunol. doi: 10.1016/j.clim.2012.01.005 – volume: 16 start-page: 121 year: 2015 ident: BFnrrheum201722_CR43 publication-title: BMC Genet. doi: 10.1186/s12863-015-0279-8 – volume: 46 start-page: 24 year: 2009 ident: BFnrrheum201722_CR174 publication-title: Cytokine doi: 10.1016/j.cyto.2008.12.001 – volume: 11 start-page: 461 year: 2015 ident: BFnrrheum201722_CR14 publication-title: Expert Opin. Drug Metab. Toxicol. doi: 10.1517/17425255.2015.1000860 – volume: 27 start-page: 19 year: 2002 ident: BFnrrheum201722_CR23 publication-title: Trends Biochem. Sci. doi: 10.1016/S0968-0004(01)01995-8 – volume: 3 start-page: 609 year: 2003 ident: BFnrrheum201722_CR4 publication-title: Nat. Rev. Immunol. doi: 10.1038/nri1148 – volume: 22 start-page: 54 year: 2011 ident: BFnrrheum201722_CR67 publication-title: Pediatr. Allergy Immunol. doi: 10.1111/j.1399-3038.2010.01111.x – volume: 36 start-page: 13 year: 2004 ident: BFnrrheum201722_CR124 publication-title: Exp. Mol. Med. doi: 10.1038/emm.2004.2 – volume: 26 start-page: 229 year: 2014 ident: BFnrrheum201722_CR151 publication-title: Semin. Immunol. doi: 10.1016/j.smim.2014.02.006 – volume: 98 start-page: 47 year: 1999 ident: BFnrrheum201722_CR187 publication-title: Cell doi: 10.1016/S0092-8674(00)80605-4 – volume: 104 start-page: 151 year: 2016 ident: BFnrrheum201722_CR134 publication-title: Pharmacol. Res. doi: 10.1016/j.phrs.2015.12.018 – volume: 69 start-page: 550 year: 2010 ident: BFnrrheum201722_CR71 publication-title: Ann. Rheum. Dis. doi: 10.1136/ard.2009.116434 – volume: 72 start-page: 185 year: 2015 ident: BFnrrheum201722_CR86 publication-title: Cytokine doi: 10.1016/j.cyto.2014.12.026 – volume: 46 start-page: 513 year: 2016 ident: BFnrrheum201722_CR122 publication-title: Eur. J. Immunol. doi: 10.1002/eji.201445388 – volume: 316 start-page: 552 year: 1985 ident: BFnrrheum201722_CR1 publication-title: Nature doi: 10.1038/316552a0 – volume: 434 start-page: 88 year: 2005 ident: BFnrrheum201722_CR179 publication-title: Nature doi: 10.1038/nature03337 – volume: 37 start-page: 204 year: 2010 ident: BFnrrheum201722_CR219 publication-title: J. Rheumatol. doi: 10.3899/jrheum.081312 – volume: 104 start-page: 487 year: 2001 ident: BFnrrheum201722_CR3 publication-title: Cell doi: 10.1016/S0092-8674(01)00237-9 – volume: 2010 start-page: 239083 year: 2010 ident: BFnrrheum201722_CR98 publication-title: Clin. Dev. Immunol. doi: 10.1155/2010/239083 – volume: 12 start-page: 100 year: 2011 ident: BFnrrheum201722_CR70 publication-title: Genes Immun. doi: 10.1038/gene.2010.44 – volume: 37 start-page: 173 year: 2008 ident: BFnrrheum201722_CR155 publication-title: Scand. J. Rheumatol. doi: 10.1080/03009740801898608 – volume: 17 start-page: 234 year: 2015 ident: BFnrrheum201722_CR50 publication-title: Arthritis Res. Ther. doi: 10.1186/s13075-015-0757-4 – volume: 20 start-page: 353 year: 2012 ident: BFnrrheum201722_CR139 publication-title: Wound Repair Regen. doi: 10.1111/j.1524-475X.2012.00785.x – volume: 16 start-page: 474 year: 2014 ident: BFnrrheum201722_CR69 publication-title: Arthritis Res. Ther. doi: 10.1186/s13075-014-0474-4 – volume: 179 start-page: 7949 year: 2007 ident: BFnrrheum201722_CR169 publication-title: J. Immunol. doi: 10.4049/jimmunol.179.11.7949 – volume: 12 start-page: 147 year: 2013 ident: BFnrrheum201722_CR11 publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd3930 – volume: 23 start-page: 23 year: 2005 ident: BFnrrheum201722_CR209 publication-title: Annu. Rev. Immunol. doi: 10.1146/annurev.immunol.23.021704.115839 – volume: 12 start-page: 49 year: 2016 ident: BFnrrheum201722_CR7 publication-title: Nat. Rev. Rheumatol. doi: 10.1038/nrrheum.2015.169 – volume: 34 start-page: 51 year: 2014 ident: BFnrrheum201722_CR195 publication-title: Rheumatol. Int. doi: 10.1007/s00296-011-2002-z – volume: 179 start-page: 2609 year: 2007 ident: BFnrrheum201722_CR110 publication-title: J. Immunol. doi: 10.4049/jimmunol.179.4.2609 – volume: 34 start-page: 107 year: 2001 ident: BFnrrheum201722_CR212 publication-title: Autoimmunity doi: 10.3109/08916930109001958 – volume: 11 start-page: R24 year: 2009 ident: BFnrrheum201722_CR146 publication-title: Arthritis Res. Ther. doi: 10.1186/ar2617 – volume: 145 start-page: 226 year: 1994 ident: BFnrrheum201722_CR31 publication-title: Res. Immunol. doi: 10.1016/S0923-2494(94)80189-4 – volume: 39 start-page: 1552 year: 2009 ident: BFnrrheum201722_CR223 publication-title: Eur. J. Immunol. doi: 10.1002/eji.200839057 – volume: 145 start-page: 235 year: 2006 ident: BFnrrheum201722_CR62 publication-title: Clin. Exp. Immunol. doi: 10.1111/j.1365-2249.2006.03141.x – volume: 10 start-page: 66 year: 2003 ident: BFnrrheum201722_CR186 publication-title: Cell Death Differ. doi: 10.1038/sj.cdd.4401187 – volume: 26 start-page: 1053 year: 2015 ident: BFnrrheum201722_CR172 publication-title: J. Am. Soc. Nephrol. doi: 10.1681/ASN.2014030233 – volume: 10 start-page: 26 year: 2003 ident: BFnrrheum201722_CR177 publication-title: Cell Death Differ. doi: 10.1038/sj.cdd.4401186 – volume: 112 start-page: 1332 year: 2003 ident: BFnrrheum201722_CR192 publication-title: J. Clin. Invest. doi: 10.1172/JCI200319209 – volume: 37 start-page: 1407 year: 2007 ident: BFnrrheum201722_CR117 publication-title: Eur. J. Immunol. doi: 10.1002/eji.200636872 – volume: 171 start-page: 1061 year: 2003 ident: BFnrrheum201722_CR188 publication-title: J. Immunol. doi: 10.4049/jimmunol.171.2.1061 – ident: BFnrrheum201722_CR53 – volume: 18 start-page: 712 year: 2011 ident: BFnrrheum201722_CR178 publication-title: Cell Death Differ. doi: 10.1038/cdd.2010.155 – volume: 69 start-page: 813 year: 2010 ident: BFnrrheum201722_CR40 publication-title: Ann. Rheum. Dis. doi: 10.1136/ard.2009.109579 – volume: 120 start-page: 3629 year: 2010 ident: BFnrrheum201722_CR224 publication-title: J. Clin. Invest. doi: 10.1172/JCI42933 – volume: 21 start-page: 293 year: 2009 ident: BFnrrheum201722_CR28 publication-title: Semin. Immunol. doi: 10.1016/j.smim.2009.05.012 – volume: 74 start-page: 526 year: 2015 ident: BFnrrheum201722_CR207 publication-title: Ann. Rheum. Dis. doi: 10.1136/annrheumdis-2013-203991 – volume: 40 start-page: 83 year: 2008 ident: BFnrrheum201722_CR66 publication-title: Nat. Genet. doi: 10.1038/ng.2007.47 – volume: 180 start-page: 1059 year: 2012 ident: BFnrrheum201722_CR101 publication-title: Am. J. Pathol. doi: 10.1016/j.ajpath.2011.11.018 – volume: 114 start-page: 1603 year: 2004 ident: BFnrrheum201722_CR57 publication-title: J. Clin. Invest. doi: 10.1172/JCI20742 – volume: 11 start-page: e0157105 year: 2016 ident: BFnrrheum201722_CR20 publication-title: PLoS ONE doi: 10.1371/journal.pone.0157105 – volume: 153 start-page: 85 year: 1996 ident: BFnrrheum201722_CR32 publication-title: Immunol. Rev. doi: 10.1111/j.1600-065X.1996.tb00921.x – volume: 163 start-page: 401 year: 2003 ident: BFnrrheum201722_CR95 publication-title: Am. J. Pathol. doi: 10.1016/S0002-9440(10)63670-X – volume: 24 start-page: 161 year: 2009 ident: BFnrrheum201722_CR73 publication-title: Nephrol. Dial. Transplant. doi: 10.1093/ndt/gfn461 – volume: 61 start-page: 534 year: 2015 ident: BFnrrheum201722_CR15 publication-title: Gerontology doi: 10.1159/000371845 – volume: 28 start-page: 57 year: 2010 ident: BFnrrheum201722_CR54 publication-title: Annu. Rev. Immunol. doi: 10.1146/annurev-immunol-030409-101243 – volume: 43 start-page: 175 year: 2014 ident: BFnrrheum201722_CR85 publication-title: Scand. J. Rheumatol. doi: 10.3109/03009742.2013.848931 – volume: 14 start-page: 293 year: 1995 ident: BFnrrheum201722_CR113 publication-title: Clin. Rheumatol. doi: 10.1007/BF02208342 – volume: 60 start-page: 2242 year: 2009 ident: BFnrrheum201722_CR39 publication-title: Arthritis Rheum. doi: 10.1002/art.24721 – volume: 272 start-page: 32401 year: 1997 ident: BFnrrheum201722_CR159 publication-title: J. Biol. Chem. doi: 10.1074/jbc.272.51.32401 – volume: 7 start-page: R604 year: 2005 ident: BFnrrheum201722_CR59 publication-title: Arthritis Res. Ther. doi: 10.1186/ar1722 – volume: 10 start-page: 335 year: 2011 ident: BFnrrheum201722_CR205 publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd3436 – volume: 46 start-page: 3251 year: 2002 ident: BFnrrheum201722_CR47 publication-title: Arthritis Rheum. doi: 10.1002/art.10681 – volume: 335 start-page: 1643 year: 1996 ident: BFnrrheum201722_CR184 publication-title: N. Engl. J. Med. doi: 10.1056/NEJM199611283352204 – volume: 9 start-page: e112545 year: 2014 ident: BFnrrheum201722_CR150 publication-title: PLoS ONE doi: 10.1371/journal.pone.0112545 – volume: 52 start-page: 623 year: 2013 ident: BFnrrheum201722_CR42 publication-title: Rheumatology doi: 10.1093/rheumatology/kes339 – volume: 53 start-page: 289 year: 2011 ident: BFnrrheum201722_CR158 publication-title: Cytokine doi: 10.1016/j.cyto.2010.12.003 – volume: 136 start-page: 757 year: 2015 ident: BFnrrheum201722_CR149 publication-title: J. Allergy Clin. Immunol. doi: 10.1016/j.jaci.2014.12.1936 – volume: 29 start-page: 79 year: 2008 ident: BFnrrheum201722_CR74 publication-title: Immunity doi: 10.1016/j.immuni.2008.04.021 – volume: 94 start-page: 569 year: 2012 ident: BFnrrheum201722_CR225 publication-title: Transplantation doi: 10.1097/TP.0b013e318264d3ef – volume: 135 start-page: 2109 year: 2015 ident: BFnrrheum201722_CR144 publication-title: J. Invest. Dermatol. doi: 10.1038/jid.2015.110 – volume: 66 start-page: 2728 year: 2014 ident: BFnrrheum201722_CR221 publication-title: Arthritis Rheumatol. doi: 10.1002/art.38755 – volume: 115 start-page: 3051 year: 2010 ident: BFnrrheum201722_CR118 publication-title: Blood doi: 10.1182/blood-2009-08-239145 – volume: 223 start-page: 202 year: 2008 ident: BFnrrheum201722_CR131 publication-title: Immunol. Rev. doi: 10.1111/j.1600-065X.2008.00633.x – volume: 5 start-page: 511 year: 2014 ident: BFnrrheum201722_CR9 publication-title: Front. Immunol. doi: 10.3389/fimmu.2014.00511 – volume: 147 start-page: 144 year: 2013 ident: BFnrrheum201722_CR83 publication-title: Clin. Immunol. doi: 10.1016/j.clim.2013.03.002 – volume: 8 start-page: 1405 year: 2002 ident: BFnrrheum201722_CR128 publication-title: Nat. Med. doi: 10.1038/nm1202-796 – volume: 15 start-page: 353 year: 2004 ident: BFnrrheum201722_CR27 publication-title: Cytokine Growth Factor Rev. doi: 10.1016/j.cytogfr.2004.03.011 – volume: 19 start-page: 317 year: 2001 ident: BFnrrheum201722_CR58 publication-title: Clin. Exp. Rheumatol. – volume: 28 start-page: 95 year: 2001 ident: BFnrrheum201722_CR46 publication-title: J. Rheumatol. – volume: 51 start-page: 47 year: 2012 ident: BFnrrheum201722_CR41 publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/ker345 – volume: 66 start-page: 3289 year: 2014 ident: BFnrrheum201722_CR202 publication-title: Arthritis Rheumatol. doi: 10.1002/art.38806 – volume: 15 start-page: 837 year: 2001 ident: BFnrrheum201722_CR153 publication-title: Immunity doi: 10.1016/S1074-7613(01)00232-1 – volume: 10 start-page: 1088 year: 2004 ident: BFnrrheum201722_CR125 publication-title: Nat. Med. doi: 10.1038/nm1107 – volume: 356 start-page: 314 year: 1992 ident: BFnrrheum201722_CR181 publication-title: Nature doi: 10.1038/356314a0 – volume: 71 start-page: 1134 year: 2012 ident: BFnrrheum201722_CR135 publication-title: Ann. Rheum. Dis. doi: 10.1136/annrheumdis-2011-150573 – volume: 135 start-page: 1986 year: 2015 ident: BFnrrheum201722_CR171 publication-title: J. Invest. Dermatol. doi: 10.1038/jid.2015.124 – volume: 111 start-page: 2289 year: 2014 ident: BFnrrheum201722_CR56 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1321071111 – volume: 183 start-page: 4853 year: 2009 ident: BFnrrheum201722_CR226 publication-title: J. Immunol. doi: 10.4049/jimmunol.0901112 – volume: 53 start-page: 1896 year: 2014 ident: BFnrrheum201722_CR111 publication-title: Rheumatology doi: 10.1093/rheumatology/keu171 – volume: 18 start-page: 473 year: 2014 ident: BFnrrheum201722_CR10 publication-title: Expert Opin. Ther. Targets doi: 10.1517/14728222.2014.888415 – volume: 10 start-page: 365 year: 2014 ident: BFnrrheum201722_CR17 publication-title: Nat. Rev. Rheumatol. doi: 10.1038/nrrheum.2014.33 – volume: 43 start-page: 44 year: 2013 ident: BFnrrheum201722_CR170 publication-title: J. Autoimmun. doi: 10.1016/j.jaut.2013.03.002 – ident: BFnrrheum201722_CR176 – volume: 205 start-page: 1049 year: 2008 ident: BFnrrheum201722_CR75 publication-title: J. Exp. Med. doi: 10.1084/jem.20071364 – volume: 35 start-page: 3581 year: 2005 ident: BFnrrheum201722_CR104 publication-title: Eur. J. Immunol. doi: 10.1002/eji.200535421 – volume: 20 start-page: 863 year: 2002 ident: BFnrrheum201722_CR112 publication-title: Clin. Exp. Rheumatol. – volume: 80 start-page: 129 year: 1996 ident: BFnrrheum201722_CR109 publication-title: Clin. Immunol. Immunopathol. doi: 10.1006/clin.1996.0106 – volume: 81 start-page: 935 year: 1995 ident: BFnrrheum201722_CR183 publication-title: Cell doi: 10.1016/0092-8674(95)90013-6 – volume: 13 start-page: R51 year: 2011 ident: BFnrrheum201722_CR157 publication-title: Arthritis Res. Ther. doi: 10.1186/ar3294 – volume: 191 start-page: 5420 year: 2013 ident: BFnrrheum201722_CR88 publication-title: J. Immunol. doi: 10.4049/jimmunol.1301475 – volume: 7 start-page: 1492 year: 2014 ident: BFnrrheum201722_CR213 publication-title: Mucosal Immunol. doi: 10.1038/mi.2014.37 – volume: 228 start-page: 225 year: 2009 ident: BFnrrheum201722_CR25 publication-title: Immunol. Rev. doi: 10.1111/j.1600-065X.2008.00755.x – volume: 15 start-page: 1 year: 2015 ident: BFnrrheum201722_CR12 publication-title: Expert Opin. Biol. Ther. doi: 10.1517/14712598.2015.973398 – volume: 66 start-page: 2762 year: 2014 ident: BFnrrheum201722_CR89 publication-title: Arthritis Rheumatol. doi: 10.1002/art.38770 – volume: 47 start-page: 442 year: 2008 ident: BFnrrheum201722_CR160 publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/ken006 – volume: 35 start-page: 1435 year: 2015 ident: BFnrrheum201722_CR94 publication-title: Rheumatol. Int. doi: 10.1007/s00296-015-3277-2 – volume: 229 start-page: 216 year: 2009 ident: BFnrrheum201722_CR107 publication-title: Immunol. Rev. doi: 10.1111/j.1600-065X.2009.00774.x – volume: 488 start-page: 222 year: 2012 ident: BFnrrheum201722_CR138 publication-title: Nature doi: 10.1038/nature11242 – volume: 50 start-page: 1850 year: 2004 ident: BFnrrheum201722_CR116 publication-title: Arthritis Rheum. doi: 10.1002/art.20255 – volume: 42 start-page: 1393 year: 2012 ident: BFnrrheum201722_CR230 publication-title: Eur. J. Immunol. doi: 10.1002/eji.201142162 – volume: 15 start-page: 2825 year: 2015 ident: BFnrrheum201722_CR51 publication-title: Am. J. Transplant. doi: 10.1111/ajt.13377 – volume: 20 start-page: 725 year: 2011 ident: BFnrrheum201722_CR92 publication-title: Exp. Dermatol. doi: 10.1111/j.1600-0625.2011.01304.x – volume: 37 start-page: 342 year: 2011 ident: BFnrrheum201722_CR227 publication-title: J. Autoimmun. doi: 10.1016/j.jaut.2011.10.001 – volume: 2012 start-page: 265868 year: 2012 ident: BFnrrheum201722_CR105 publication-title: Clin. Dev. Immunol. doi: 10.1155/2012/265868 – volume: 183 start-page: 3770 year: 2009 ident: BFnrrheum201722_CR108 publication-title: J. Immunol. doi: 10.4049/jimmunol.0901637 – volume: 46 start-page: 1063 year: 2007 ident: BFnrrheum201722_CR143 publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/kem063 – volume: 190 start-page: 1076 year: 2013 ident: BFnrrheum201722_CR220 publication-title: J. Immunol. doi: 10.4049/jimmunol.1202659 – volume: 195 start-page: 2429 year: 2015 ident: BFnrrheum201722_CR141 publication-title: J. Immunol. doi: 10.4049/jimmunol.1500356 – volume: 26 start-page: 545 year: 2007 ident: BFnrrheum201722_CR180 publication-title: Immunity doi: 10.1016/j.immuni.2007.05.004 – volume: 175 start-page: 1295 year: 2005 ident: BFnrrheum201722_CR140 publication-title: J. Immunol. doi: 10.4049/jimmunol.175.2.1295 – volume: 45 start-page: 523 year: 2008 ident: BFnrrheum201722_CR103 publication-title: Mol. Immunol. doi: 10.1016/j.molimm.2007.05.013 – volume: 31 start-page: 29 year: 2011 ident: BFnrrheum201722_CR65 publication-title: Ann. Saudi Med. doi: 10.4103/0256-4947.75775 – volume: 30 start-page: 4126 year: 1998 ident: BFnrrheum201722_CR2 publication-title: Transplant. Proc. doi: 10.1016/S0041-1345(98)01365-7 – volume: 244 start-page: 197 year: 2011 ident: BFnrrheum201722_CR121 publication-title: Immunol. Rev. doi: 10.1111/j.1600-065X.2011.01063.x – volume: 26 start-page: 183 year: 2014 ident: BFnrrheum201722_CR210 publication-title: Semin. Immunol. doi: 10.1016/j.smim.2014.02.005 – volume: 11 start-page: 1426 year: 2000 ident: BFnrrheum201722_CR60 publication-title: J. Am. Soc. Nephrol. doi: 10.1681/ASN.V1181426 – volume: 259 start-page: 990 year: 1993 ident: BFnrrheum201722_CR30 publication-title: Science doi: 10.1126/science.7679801 – volume: 14 start-page: 115 year: 2014 ident: BFnrrheum201722_CR191 publication-title: Clin. Exp. Med. doi: 10.1007/s10238-012-0226-1 – volume: 12 start-page: 625 year: 2016 ident: BFnrrheum201722_CR13 publication-title: Nat. Rev. Rheumatol. doi: 10.1038/nrrheum.2016.145 – volume: 290 start-page: 209 year: 2014 ident: BFnrrheum201722_CR203 publication-title: Cell. Immunol. doi: 10.1016/j.cellimm.2014.07.004 – volume: 148 start-page: 410 year: 2007 ident: BFnrrheum201722_CR102 publication-title: Clin. Exp. Immunol. doi: 10.1111/j.1365-2249.2007.03363.x – volume: 54 start-page: 1451 year: 2006 ident: BFnrrheum201722_CR142 publication-title: Arthritis Rheum. doi: 10.1002/art.21821 – volume: 244 start-page: 99 year: 2011 ident: BFnrrheum201722_CR152 publication-title: Immunol. Rev. doi: 10.1111/j.1600-065X.2011.01054.x – volume: 205 start-page: 2457 year: 2008 ident: BFnrrheum201722_CR87 publication-title: J. Exp. Med. doi: 10.1084/jem.20072378 – volume: 157 start-page: 3159 year: 1996 ident: BFnrrheum201722_CR36 publication-title: J. Immunol. doi: 10.4049/jimmunol.157.7.3159 – volume: 129 start-page: 249 year: 2008 ident: BFnrrheum201722_CR81 publication-title: Clin. Immunol. doi: 10.1016/j.clim.2008.07.014 – volume: 180 start-page: 1454 year: 2012 ident: BFnrrheum201722_CR97 publication-title: Am. J. Pathol. doi: 10.1016/j.ajpath.2012.01.003 – volume: 177 start-page: 6433 year: 2006 ident: BFnrrheum201722_CR164 publication-title: J. Immunol. doi: 10.4049/jimmunol.177.9.6433 – volume: 40 start-page: 579 year: 2013 ident: BFnrrheum201722_CR208 publication-title: J. Rheumatol. doi: 10.3899/jrheum.120886 – volume: 114 start-page: 181 year: 2003 ident: BFnrrheum201722_CR26 publication-title: Cell doi: 10.1016/S0092-8674(03)00521-X – volume: 2013 start-page: 340751 year: 2013 ident: BFnrrheum201722_CR106 publication-title: Clin. Dev. Immunol. doi: 10.1155/2013/340751 – ident: BFnrrheum201722_CR52 – volume: 19 start-page: 953 year: 2008 ident: BFnrrheum201722_CR96 publication-title: J. Am. Soc. Nephrol. doi: 10.1681/ASN.2007060706 – volume: 181 start-page: 5912 year: 2008 ident: BFnrrheum201722_CR200 publication-title: J. Immunol. doi: 10.4049/jimmunol.181.9.5912 – volume: 154 start-page: 1470 year: 1995 ident: BFnrrheum201722_CR35 publication-title: J. Immunol. doi: 10.4049/jimmunol.154.3.1470 – volume: 1832 start-page: 1744 year: 2013 ident: BFnrrheum201722_CR162 publication-title: Biochim. Biophys. Acta doi: 10.1016/j.bbadis.2013.05.032 – volume: 42 start-page: 97 year: 2013 ident: BFnrrheum201722_CR84 publication-title: Scand. J. Rheumatol. doi: 10.3109/03009742.2012.727026 – volume: 42 start-page: 403 year: 2012 ident: BFnrrheum201722_CR222 publication-title: Eur. J. Immunol. doi: 10.1002/eji.201141659 – volume: 9 start-page: 705 year: 2013 ident: BFnrrheum201722_CR218 publication-title: Nat. Rev. Rheumatol. doi: 10.1038/nrrheum.2013.136 – volume: 24 start-page: 1177 year: 2015 ident: BFnrrheum201722_CR44 publication-title: Lupus doi: 10.1177/0961203315583543 – volume: 28 start-page: 290 year: 1998 ident: BFnrrheum201722_CR123 publication-title: Eur. J. Immunol. doi: 10.1002/(SICI)1521-4141(199801)28:01<290::AID-IMMU290>3.0.CO;2-S – volume: 35 start-page: 2359 year: 2008 ident: BFnrrheum201722_CR72 publication-title: J. Rheumatol. doi: 10.3899/jrheum.080120 – volume: 268 start-page: 1347 year: 1995 ident: BFnrrheum201722_CR182 publication-title: Science doi: 10.1126/science.7539157 – volume: 33 start-page: 2792 year: 2003 ident: BFnrrheum201722_CR211 publication-title: Eur. J. Immunol. doi: 10.1002/eji.200324088 – volume: 42 start-page: 1159 year: 2015 ident: BFnrrheum201722_CR61 publication-title: Immunity doi: 10.1016/j.immuni.2015.05.012 – volume: 171 start-page: 115 year: 2003 ident: BFnrrheum201722_CR145 publication-title: J. Immunol. doi: 10.4049/jimmunol.171.1.115 – volume: 69 start-page: 301 year: 2010 ident: BFnrrheum201722_CR156 publication-title: Ann. Rheum. Dis. doi: 10.1136/ard.2008.090548 – volume: 66 start-page: 836 year: 2014 ident: BFnrrheum201722_CR8 publication-title: Pharmacol. Rep. doi: 10.1016/j.pharep.2014.05.004 – volume: 188 start-page: 3188 year: 2012 ident: BFnrrheum201722_CR228 publication-title: J. Immunol. doi: 10.4049/jimmunol.1103354 – volume: 17 start-page: 35 year: 2010 ident: BFnrrheum201722_CR24 publication-title: Cell Death Differ. doi: 10.1038/cdd.2009.114 – volume: 27 start-page: 55 year: 2015 ident: BFnrrheum201722_CR204 publication-title: Int. Immunol. doi: 10.1093/intimm/dxu102 – volume: 11 start-page: R143 year: 2009 ident: BFnrrheum201722_CR175 publication-title: Arthritis Res. Ther. doi: 10.1186/ar2816 – volume: 59 start-page: 198 year: 2010 ident: BFnrrheum201722_CR120 publication-title: J. Dermatol. Sci. doi: 10.1016/j.jdermsci.2010.06.011 – volume: 69 start-page: 305 year: 2010 ident: BFnrrheum201722_CR115 publication-title: Ann. Rheum. Dis. doi: 10.1136/ard.2008.096495 – volume: 79 start-page: 369 year: 2006 ident: BFnrrheum201722_CR199 publication-title: J. Leukoc. Biol. doi: 10.1189/jlb.0505238 – volume: 4 start-page: 255 year: 2003 ident: BFnrrheum201722_CR185 publication-title: Nat. Immunol. doi: 10.1038/ni894 – volume: 11 start-page: 321 year: 2012 ident: BFnrrheum201722_CR217 publication-title: Autoimmun. Rev. doi: 10.1016/j.autrev.2011.05.001 – volume: 332 start-page: 858 year: 2010 ident: BFnrrheum201722_CR194 publication-title: J. Pharmacol. Exp. Ther. doi: 10.1124/jpet.109.159517 – volume: 192 start-page: 4083 year: 2014 ident: BFnrrheum201722_CR49 publication-title: J. Immunol. doi: 10.4049/jimmunol.1303239 – ident: BFnrrheum201722_CR19 doi: 10.1002/art.39943 – volume: 177 start-page: 2610 year: 2006 ident: BFnrrheum201722_CR163 publication-title: J. Immunol. doi: 10.4049/jimmunol.177.4.2610 – volume: 113 start-page: 89 year: 2004 ident: BFnrrheum201722_CR126 publication-title: Immunology doi: 10.1111/j.1365-2567.2004.01952.x – volume: 50 start-page: 150 year: 2012 ident: BFnrrheum201722_CR196 publication-title: Mol. Immunol. doi: 10.1016/j.molimm.2012.01.007 – volume: 205 start-page: 1037 year: 2008 ident: BFnrrheum201722_CR76 publication-title: J. Exp. Med. doi: 10.1084/jem.20072528 – volume: 81 start-page: 239 year: 1996 ident: BFnrrheum201722_CR114 publication-title: Clin. Immunol. Immunopathol. doi: 10.1006/clin.1996.0184 – volume: 66 start-page: 228 year: 2007 ident: BFnrrheum201722_CR216 publication-title: Ann. Rheum. Dis. doi: 10.1136/ard.2006.055111 – volume: 691 start-page: 279 year: 2011 ident: BFnrrheum201722_CR79 publication-title: Adv. Exp. Med. Biol. doi: 10.1007/978-1-4419-6612-4_29 – volume: 19 start-page: 695 year: 2008 ident: BFnrrheum201722_CR167 publication-title: J. Am. Soc. Nephrol. doi: 10.1681/ASN.2007050577 – volume: 12 start-page: 205 year: 2016 ident: BFnrrheum201722_CR214 publication-title: Nat. Rev. Nephrol. doi: 10.1038/nrneph.2015.206 – volume: 156 start-page: 3133 year: 1996 ident: BFnrrheum201722_CR33 publication-title: J. Immunol. doi: 10.4049/jimmunol.156.9.3133 – volume: 169 start-page: 4628 year: 2002 ident: BFnrrheum201722_CR68 publication-title: J. Immunol. doi: 10.4049/jimmunol.169.8.4628 – volume: 89 start-page: 113 year: 2016 ident: BFnrrheum201722_CR148 publication-title: Kidney Int. doi: 10.1038/ki.2015.280 – volume: 35 start-page: 1137 year: 2013 ident: BFnrrheum201722_CR166 publication-title: Clin. Ther. doi: 10.1016/j.clinthera.2013.06.008 – volume: 647 start-page: 8 year: 2009 ident: BFnrrheum201722_CR29 publication-title: Adv. Exp. Med. Biol. doi: 10.1007/978-0-387-89520-8_2 – volume: 12 start-page: R150 year: 2010 ident: BFnrrheum201722_CR64 publication-title: Arthritis Res. Ther. doi: 10.1186/ar3100 – volume: 165 start-page: 2089 year: 2012 ident: BFnrrheum201722_CR99 publication-title: Br. J. Pharmacol. doi: 10.1111/j.1476-5381.2011.01753.x – volume: 987 start-page: 230 year: 2003 ident: BFnrrheum201722_CR129 publication-title: Ann. NY Acad. Sci. doi: 10.1111/j.1749-6632.2003.tb06052.x – volume: 76 start-page: 537 year: 2015 ident: BFnrrheum201722_CR16 publication-title: Cytokine doi: 10.1016/j.cyto.2015.07.014 – volume: 89 start-page: 517 year: 2011 ident: BFnrrheum201722_CR133 publication-title: J. Leukoc. Biol. doi: 10.1189/jlb.0910528 – volume: 364 start-page: 806 year: 1993 ident: BFnrrheum201722_CR197 publication-title: Nature doi: 10.1038/364806a0 – volume: 33 start-page: 144 year: 2012 ident: BFnrrheum201722_CR6 publication-title: Trends Immunol. doi: 10.1016/j.it.2011.10.004 – volume: 178 start-page: 7325 year: 2007 ident: BFnrrheum201722_CR80 publication-title: J. Immunol. doi: 10.4049/jimmunol.178.11.7325 – volume: 16 start-page: 467 year: 2014 ident: BFnrrheum201722_CR136 publication-title: Arthritis Res. Ther. doi: 10.1186/s13075-014-0467-3 – volume: 647 start-page: 146 year: 2009 ident: BFnrrheum201722_CR132 publication-title: Adv. Exp. Med. Biol. doi: 10.1007/978-0-387-89520-8_10 – volume: 12 start-page: R33 year: 2010 ident: BFnrrheum201722_CR190 publication-title: Arthritis Res. Ther. doi: 10.1186/ar2941 – volume: 196 start-page: 2145 year: 2016 ident: BFnrrheum201722_CR229 publication-title: J. Immunol. doi: 10.4049/jimmunol.1501877 – volume: 111 start-page: 1505 year: 2003 ident: BFnrrheum201722_CR130 publication-title: J. Clin. Invest. doi: 10.1172/JCI200317662 – volume: 183 start-page: 5350 year: 2009 ident: BFnrrheum201722_CR82 publication-title: J. Immunol. doi: 10.4049/jimmunol.0802645 – volume: 9 start-page: 271 year: 2009 ident: BFnrrheum201722_CR5 publication-title: Nat. Rev. Immunol. doi: 10.1038/nri2526 – volume: 126 start-page: 318 year: 2016 ident: BFnrrheum201722_CR201 publication-title: J. Clin. Invest. doi: 10.1172/JCI81217 – volume: 8 start-page: 76 year: 2016 ident: BFnrrheum201722_CR22 publication-title: Genome Med. doi: 10.1186/s13073-016-0329-5 – volume: 40 start-page: 1216 year: 2008 ident: BFnrrheum201722_CR38 publication-title: Nat. Genet. doi: 10.1038/ng.233 – volume: 50 start-page: 1412 year: 2004 ident: BFnrrheum201722_CR215 publication-title: Arthritis Rheum. doi: 10.1002/art.20221 – volume: 261 start-page: 1328 year: 1993 ident: BFnrrheum201722_CR34 publication-title: Science doi: 10.1126/science.7689748 – volume: 15 start-page: 135 year: 2008 ident: BFnrrheum201722_CR63 publication-title: Egypt. J. Immunol. – volume: 3 start-page: 642 year: 2003 ident: BFnrrheum201722_CR137 publication-title: Nat. Rev. Immunol. doi: 10.1038/nri1151 – volume: 11 start-page: R16 year: 2009 ident: BFnrrheum201722_CR189 publication-title: Arthritis Res. Ther. doi: 10.1186/ar2607 – volume: 48 start-page: 719 year: 2003 ident: BFnrrheum201722_CR45 publication-title: Arthritis Rheum. doi: 10.1002/art.10856 – volume: 19 start-page: 1253 year: 2005 ident: BFnrrheum201722_CR100 publication-title: FASEB J. doi: 10.1096/fj.04-3556com – volume: 176 start-page: 1889 year: 2006 ident: BFnrrheum201722_CR173 publication-title: J. Immunol. doi: 10.4049/jimmunol.176.3.1889 – reference: 23748045 - Biochim Biophys Acta. 2013 Oct;1832(10):1744-55 – reference: 24559200 - Scand J Rheumatol. 2014;43(2):175 – reference: 11239407 - Cell. 2001 Feb 23;104(4):487-501 – reference: 18411341 - J Exp Med. 2008 May 12;205(5):1037-48 – reference: 18941180 - J Immunol. 2008 Nov 1;181(9):5912-29 – reference: 10906156 - J Am Soc Nephrol. 2000 Aug;11(8):1426-38 – reference: 22902792 - Transplantation. 2012 Sep 27;94(6):569-74 – reference: 24614588 - Nat Rev Rheumatol. 2014 Jun;10(6):365-73 – reference: 16649193 - Arthritis Rheum. 2006 May;54(5):1451-62 – reference: 22169337 - Trends Immunol. 2012 Mar;33(3):144-52 – reference: 15450251 - Cytokine Growth Factor Rev. 2004 Oct;15(5):353-66 – reference: 23935647 - Clin Dev Immunol. 2013;2013:340751 – reference: 26139432 - Am J Transplant. 2015 Nov;15(11):2825-36 – reference: 25929716 - Rheumatol Int. 2015 Aug;35(8):1435-7 – reference: 12655296 - Cell Death Differ. 2003 Jan;10(1):66-75 – reference: 20306696 - Egypt J Immunol. 2008;15(2):135-43 – reference: 26198030 - Cytokine. 2015 Dec;76(2):537-44 – reference: 24018550 - Nat Rev Rheumatol. 2013 Dec;9(12):705-20 – reference: 19933369 - J Pharmacol Exp Ther. 2010 Mar;332(3):858-65 – reference: 20936139 - Clin Dev Immunol. 2010;2010:239083 – reference: 22801499 - Nature. 2012 Aug 9;488(7410):222-5 – reference: 12887920 - Cell. 2003 Jul 25;114(2):181-90 – reference: 25359291 - Arthritis Res Ther. 2014 Oct 30;16(5):474 – reference: 25680454 - J Allergy Clin Immunol. 2015 Sep;136(3):757-68 – reference: 9865320 - Transplant Proc. 1998 Dec;30(8):4126-7 – reference: 25405351 - PLoS One. 2014 Nov 18;9(11):e112545 – reference: 25084560 - Cell Immunol. 2014 Aug;290(2):209-16 – reference: 18025243 - J Immunol. 2007 Dec 1;179(11):7949-58 – reference: 22087016 - Rheumatology (Oxford). 2012 Jan;51(1):47-51 – reference: 22214837 - Am J Pathol. 2012 Mar;180(3):1059-67 – reference: 14515263 - Eur J Immunol. 2003 Oct;33(10):2792-800 – reference: 17602748 - Mol Immunol. 2008 Jan;45(2):523-33 – reference: 14962968 - Ann Rheum Dis. 2004 Mar;63(3):310-7 – reference: 10551889 - J Biol Chem. 1999 Nov 12;274(46):33166-76 – reference: 21672030 - Exp Dermatol. 2011 Sep;20(9):725-31 – reference: 24636536 - Semin Immunol. 2014 Jun;26(3):229-36 – reference: 7540117 - Cell. 1995 Jun 16;81(6):935-46 – reference: 24965881 - Arthritis Rheumatol. 2014 Oct;66(10):2728-38 – reference: 19786544 - J Immunol. 2009 Oct 15;183(8):4853-7 – reference: 25789702 - J Invest Dermatol. 2015 Aug;135(8):2109-18 – reference: 26804020 - Nat Rev Nephrol. 2016 Apr;12(4):205-16 – reference: 24817699 - Rheumatology (Oxford). 2014 Oct;53(10):1896-900 – reference: 21792649 - Rheumatol Int. 2014 Jan;34(1):51-7 – reference: 21143648 - Pediatr Allergy Immunol. 2011 Feb;22(1 Pt 1):54-9 – reference: 11069062 - Eur J Immunol. 2000 Oct;30(10):2815-23 – reference: 20724115 - J Dermatol Sci. 2010 Sep;59(3):198-203 – reference: 12577054 - Nat Immunol. 2003 Mar;4(3):255-60 – reference: 15466914 - Int Immunol. 2004 Nov;16(11):1583-94 – reference: 21153342 - Adv Exp Med Biol. 2011;691:383-90 – reference: 15578092 - J Clin Invest. 2004 Dec;114(11):1603-11 – reference: 7529804 - J Immunol. 1995 Feb 1;154(3):1470-80 – reference: 19426224 - Immunol Rev. 2009 May;229(1):216-31 – reference: 24469824 - Proc Natl Acad Sci U S A. 2014 Feb 11;111(6):2289-94 – reference: 20187936 - Arthritis Res Ther. 2010;12(1):R33 – reference: 20861858 - Genes Immun. 2011 Mar;12(2):100-9 – reference: 19760072 - Adv Exp Med Biol. 2009;647:146-55 – reference: 2993897 - Nature. 1985 Aug 8-14;316(6028):552-4 – reference: 18059267 - Nat Genet. 2008 Jan;40(1):83-9 – reference: 15031666 - Exp Mol Med. 2004 Feb 29;36(1):13-22 – reference: 19435719 - Ann Rheum Dis. 2010 May;69(5):813-6 – reference: 20139096 - Blood. 2010 Apr 15;115(15):3051-7 – reference: 17056575 - J Immunol. 2006 Nov 1;177(9):6433-9 – reference: 22063316 - J Autoimmun. 2011 Dec;37(4):342-51 – reference: 25044706 - Arthritis Rheumatol. 2014 Oct;66(10):2762-72 – reference: 22127708 - Arthritis Rheum. 2011 Dec;63(12):3918-30 – reference: 18571443 - Immunity. 2008 Jul 18;29(1):79-89 – reference: 26474561 - BMC Genet. 2015 Oct 16;16:121 – reference: 24347569 - Ann Rheum Dis. 2015 Mar;74(3):526-31 – reference: 18794853 - Nat Genet. 2008 Oct;40(10):1216-23 – reference: 19680262 - Cell Death Differ. 2010 Jan;17 (1):35-45 – reference: 8938100 - Clin Immunol Immunopathol. 1996 Dec;81(3):239-43 – reference: 25270074 - J Am Soc Nephrol. 2015 May;26(5):1053-70 – reference: 19499519 - Eur J Immunol. 2009 Jun;39(6):1552-63 – reference: 25200589 - Arch Dermatol Res. 2014 Dec;306(10):927-32 – reference: 17359498 - Clin Exp Immunol. 2007 Jun;148(3):410-8 – reference: 26773716 - Eur J Immunol. 2016 Mar;46(3):513-22 – reference: 27294371 - PLoS One. 2016 Jun 13;11(6):e0157105 – reference: 22294625 - Ann Rheum Dis. 2012 Jul;71(7):1134-42 – reference: 7539157 - Science. 1995 Jun 2;268(5215):1347-9 – reference: 11407087 - Clin Exp Rheumatol. 2001 May-Jun;19(3):317-20 – reference: 22330679 - Am J Pathol. 2012 Apr;180(4):1454-64 – reference: 19760064 - Adv Exp Med Biol. 2009;647:8-36 – reference: 25411043 - Int Immunol. 2015 Jan;27(1):55-62 – reference: 19319144 - Nat Rev Immunol. 2009 Apr;9(4):271-85 – reference: 7689748 - Science. 1993 Sep 3;261(5126):1328-30 – reference: 22306512 - Clin Immunol. 2012 Apr;143(1):39-44 – reference: 19222863 - Arthritis Res Ther. 2009;11(1):R24 – reference: 12875962 - Am J Pathol. 2003 Aug;163(2):401-11 – reference: 15899047 - Arthritis Res Ther. 2005;7(3):R604-15 – reference: 19778912 - Ann Rheum Dis. 2010 Mar;69(3):550-5 – reference: 12632425 - Arthritis Rheum. 2003 Mar;48(3):719-27 – reference: 21619949 - Autoimmun Rev. 2012 Mar;11(5):321-5 – reference: 19710474 - J Immunol. 2009 Sep 15;183(6):3770-7 – reference: 23334208 - Nat Rev Drug Discov. 2013 Feb;12(2):147-68 – reference: 16424220 - J Immunol. 2006 Feb 1;176(3):1889-98 – reference: 25908480 - Lupus. 2015 Oct;24(11):1177-83 – reference: 12426559 - Nat Med. 2002 Dec;8(12):1405-13 – reference: 21532557 - Nat Rev Drug Discov. 2011 May;10(5):335-6 – reference: 12750400 - J Clin Invest. 2003 May;111(10):1505-18 – reference: 22325471 - Mol Immunol. 2012 Mar;50(3):150-9 – reference: 16330535 - J Leukoc Biol. 2006 Feb;79(2):369-77 – reference: 17675524 - J Immunol. 2007 Aug 15;179(4):2609-15 – reference: 9485208 - Eur J Immunol. 1998 Jan;28(1):290-5 – reference: 26656660 - Nat Rev Rheumatol. 2016 Jan;12(1):49-62 – reference: 19785730 - Arthritis Res Ther. 2009;11(5):R143 – reference: 23277487 - J Immunol. 2013 Feb 1;190(3):1076-84 – reference: 12483729 - Arthritis Rheum. 2002 Dec;46(12):3251-8 – reference: 7641505 - Clin Rheumatol. 1995 May;14(3):293-300 – reference: 20653937 - Arthritis Res Ther. 2010;12(4):R150 – reference: 16507116 - Arthritis Res Ther. 2006;8(1):R16 – reference: 27435189 - Genome Med. 2016 Jul 19;8(1):76 – reference: 11905840 - Autoimmunity. 2001;34(2):107-13 – reference: 24140642 - J Immunol. 2013 Dec 1;191(11):5420-9 – reference: 26398497 - Kidney Int. 2016 Jan;89(1):113-26 – reference: 22368274 - J Immunol. 2012 Apr 1;188(7):3188-98 – reference: 16879242 - Clin Exp Immunol. 2006 Aug;145(2):235-42 – reference: 25720990 - Gerontology. 2015;61(6):534-42 – reference: 26188076 - J Leukoc Biol. 2015 Sep;98(3):333-45 – reference: 25826425 - J Invest Dermatol. 2015 Aug;135(8):1986-95 – reference: 22982296 - Clin Immunol. 2012 Nov;145(2):108-21 – reference: 12508783 - Clin Exp Rheumatol. 2002 Nov-Dec;20(6):863-6 – reference: 15146410 - Arthritis Rheum. 2004 May;50(5):1412-9 – reference: 21435232 - Arthritis Res Ther. 2011 Mar 24;13(2):R51 – reference: 12960316 - J Immunol. 2003 Sep 15;171(6):2930-6 – reference: 12974479 - Nat Rev Immunol. 2003 Aug;3(8):642-55 – reference: 19786547 - J Immunol. 2009 Oct 15;183(8):5350-7 – reference: 25368616 - Front Immunol. 2014 Oct 20;5:511 – reference: 18287561 - J Am Soc Nephrol. 2008 May;19(5):953-60 – reference: 27586383 - Nat Rev Rheumatol. 2016 Nov;12 (11):625-626 – reference: 23547209 - J Rheumatol. 2013 May;40(5):579-89 – reference: 23256180 - Rheumatology (Oxford). 2013 Apr;52(4):623-30 – reference: 23598291 - Clin Immunol. 2013 May;147(2):144-50 – reference: 15771565 - Annu Rev Immunol. 2005;23:23-68 – reference: 20307208 - Annu Rev Immunol. 2010;28:57-78 – reference: 7689176 - Nature. 1993 Aug 26;364(6440):806-9 – reference: 21190865 - Cytokine. 2011 Mar;53(3):289-91 – reference: 16935912 - Ann Rheum Dis. 2007 Feb;66(2):228-34 – reference: 18411337 - J Exp Med. 2008 May 12;205(5):1049-62 – reference: 10412980 - Cell. 1999 Jul 9;98 (1):47-58 – reference: 17521581 - Immunity. 2007 May;26(5):545-7 – reference: 16051692 - FASEB J. 2005 Aug;19(10):1253-65 – reference: 16888023 - J Immunol. 2006 Aug 15;177(4):2610-20 – reference: 22029729 - Br J Pharmacol. 2012 Apr;165(7):2089-99 – reference: 22017440 - Immunol Rev. 2011 Nov;244(1):197-217 – reference: 23275079 - Clin Exp Med. 2014 May;14(2):115-20 – reference: 8764557 - Clin Immunol Immunopathol. 1996 Aug;80(2):129-38 – reference: 21106644 - J Leukoc Biol. 2011 Apr;89(4):517-23 – reference: 17429846 - Eur J Immunol. 2007 May;37(5):1407-13 – reference: 18235096 - J Am Soc Nephrol. 2008 Apr;19(4):695-703 – reference: 22105853 - Eur J Immunol. 2012 Feb;42(2):403-12 – reference: 23578591 - J Autoimmun. 2013 Jun;43:44-54 – reference: 25149988 - Pharmacol Rep. 2014 Oct;66(5):836-44 – reference: 25647275 - Cytokine. 2015 Apr;72(2):185-9 – reference: 18824582 - J Exp Med. 2008 Oct 27;205(11):2457-64 – reference: 17426140 - Rheumatology (Oxford). 2007 Jul;46(7):1063-70 – reference: 11796220 - Trends Biochem Sci. 2002 Jan;27(1):19-26 – reference: 19196727 - Ann Rheum Dis. 2010 Jan;69(1):305-8 – reference: 27748055 - Arthritis Rheumatol. 2016 Oct 16;:null – reference: 21153332 - Adv Exp Med Biol. 2011;691:279-88 – reference: 14597760 - J Clin Invest. 2003 Nov;112(9):1332-41 – reference: 25614274 - Expert Opin Drug Metab Toxicol. 2015 Mar;11(3):461-70 – reference: 7527580 - Res Immunol. 1994 Mar-Apr;145(3):226-34; discussion 244-9 – reference: 26070486 - Immunity. 2015 Jun 16;42(6):1159-70 – reference: 15744305 - Nature. 2005 Mar 3;434(7029):88-93 – reference: 26748035 - Pharmacol Res. 2016 Feb;104:151-5 – reference: 19147618 - Ann Rheum Dis. 2010 Jan;69(1):301-4 – reference: 12847280 - J Immunol. 2003 Jul 15;171(2):1061-9 – reference: 19196465 - Arthritis Res Ther. 2009;11(1):R16 – reference: 19233685 - Cytokine. 2009 Apr;46(1):24-35 – reference: 9010720 - Immunol Rev. 1996 Oct;153:85-106 – reference: 18843780 - J Rheumatol. 2008 Dec;35(12):2359-62 – reference: 26209626 - J Immunol. 2015 Sep 1;195(5):2429-41 – reference: 8617933 - J Immunol. 1996 May 1;156(9):3133-40 – reference: 24611063 - Front Immunol. 2014 Feb 11;5:50 – reference: 22678896 - Eur J Immunol. 2012 Jun;42(6):1393-404 – reference: 26335795 - Arthritis Res Ther. 2015 Sep 03;17:234 – reference: 23251213 - Clin Dev Immunol. 2012;2012:265868 – reference: 22564230 - Wound Repair Regen. 2012 May-Jun;20(3):353-66 – reference: 21164519 - Cell Death Differ. 2011 Apr;18(4):712-20 – reference: 25527221 - Osteoarthritis Cartilage. 2015 Jan;23 Suppl 1:S8-17 – reference: 15241467 - Genes Immun. 2004 Sep;5(6):439-43 – reference: 21245596 - Ann Saudi Med. 2011 Jan-Feb;31(1):29-34 – reference: 16002734 - J Immunol. 2005 Jul 15;175(2):1295-300 – reference: 26810223 - J Immunol. 2016 Mar 1;196 (5):2145-52 – reference: 18757243 - Clin Immunol. 2008 Nov;129(2):249-55 – reference: 22017434 - Immunol Rev. 2011 Nov;244(1):99-114 – reference: 24670803 - J Immunol. 2014 May 1;192(9):4083-92 – reference: 19595612 - Semin Immunol. 2009 Oct;21(5):293-300 – reference: 24613728 - Semin Immunol. 2014 Jun;26(3):183-90 – reference: 22017439 - Immunol Rev. 2011 Nov;244(1):188-96 – reference: 11196549 - J Rheumatol. 2001 Jan;28(1):95-101 – reference: 12727643 - Ann N Y Acad Sci. 2003 Apr;987:230-5 – reference: 15312139 - Immunology. 2004 Sep;113(1):89-98 – reference: 18310134 - Rheumatology (Oxford). 2008 Apr;47(4):442-50 – reference: 25323456 - Expert Opin Biol Ther. 2015 Jan;15(1):1-2 – reference: 16285015 - Eur J Immunol. 2005 Dec;35(12):3581-90 – reference: 23928094 - Clin Ther. 2013 Aug;35(8):1137-49 – reference: 19543369 - PLoS Genet. 2009 Jun;5(6):e1000528 – reference: 23311967 - Scand J Rheumatol. 2013;42(2):97-101 – reference: 20890040 - J Clin Invest. 2010 Oct;120(10):3629-40 – reference: 12816989 - J Immunol. 2003 Jul 1;171(1):115-26 – reference: 18465450 - Scand J Rheumatol. 2008 May-Jun;37(3):173-8 – reference: 25078097 - Arthritis Rheumatol. 2014 Dec;66(12):3289-99 – reference: 19290931 - Immunol Rev. 2009 Mar;228(1):225-40 – reference: 17513783 - J Immunol. 2007 Jun 1;178(11):7325-33 – reference: 18613838 - Immunol Rev. 2008 Jun;223:202-20 – reference: 8929361 - N Engl J Med. 1996 Nov 28;335(22):1643-9 – reference: 25359150 - Arthritis Res Ther. 2014 Oct 30;16(5):467 – reference: 12974476 - Nat Rev Immunol. 2003 Aug;3(8):609-20 – reference: 7679801 - Science. 1993 Feb 12;259(5097):990-3 – reference: 15188362 - Arthritis Rheum. 2004 Jun;50(6):1850-60 – reference: 24668485 - Handb Exp Pharmacol. 2014;220:497-512 – reference: 1372394 - Nature. 1992 Mar 26;356(6367):314-7 – reference: 8816428 - J Immunol. 1996 Oct 1;157(7):3159-64 – reference: 26657860 - J Clin Invest. 2016 Jan;126(1):318-34 – reference: 18723571 - Nephrol Dial Transplant. 2009 Jan;24(1):161-71 – reference: 15448685 - Nat Med. 2004 Oct;10(10):1088-94 – reference: 24850426 - Mucosal Immunol. 2014 Nov;7(6):1492-503 – reference: 24521424 - Expert Opin Ther Targets. 2014 Apr;18(4):473-89 – reference: 12370402 - J Immunol. 2002 Oct 15;169(8):4628-36 – reference: 9405449 - J Biol Chem. 1997 Dec 19;272(51):32401-10 – reference: 12655293 - Cell Death Differ. 2003 Jan;10(1):26-35 – reference: 20040644 - J Rheumatol. 2010 Jan;37(1):204-5 – reference: 23845567 - Am J Pathol. 2013 Sep;183(3):857-67 – reference: 11728344 - Immunity. 2001 Nov;15(5):837-46 – reference: 19644859 - Arthritis Rheum. 2009 Aug;60(8):2242-7 – reference: 17608689 - Immunology. 2007 Nov;122(3):394-400
SSID	ssj0064689
Score	2.5881033
SecondaryResourceType	review_article
Snippet	Key Points TNF inhibitors are among the most effective protein-based drugs for reducing inflammation associated with several rheumatic diseases In addition to... TNF blockers are highly efficacious at dampening inflammation and reducing symptoms in rheumatic diseases such as rheumatoid arthritis, psoriatic arthritis and...
SourceID	pubmedcentral proquest gale pubmed crossref springer
SourceType	Open Access Repository Aggregation Database Index Database Enrichment Source Publisher
StartPage	217
SubjectTerms	4-1BB Ligand - antagonists & inhibitors 4-1BB Ligand - metabolism 692/4023/1670 692/420/256 692/420/2780 692/700/565/1436 Animals Antigens Arthritis Care and treatment CD27 Ligand - antagonists & inhibitors CD27 Ligand - metabolism CD40 Ligand - antagonists & inhibitors CD40 Ligand - metabolism Cell Death Cytokine TWEAK Cytokines Dendritic cells Dendritic Cells - immunology Development and progression Fas Ligand Protein - antagonists & inhibitors Fas Ligand Protein - metabolism Genetic aspects Growth factors Health aspects Humans Immune system Immune Tolerance Ligands Lupus Lymphocyte Activation Lymphotoxin-alpha - antagonists & inhibitors Lymphotoxin-alpha - metabolism Medicine & Public Health Molecular Targeted Therapy OX40 Ligand - antagonists & inhibitors OX40 Ligand - metabolism Proteins review-article Rheumatic diseases Rheumatic Diseases - drug therapy Rheumatic Diseases - immunology Rheumatology Signal Transduction T-Lymphocytes - immunology TNF-Related Apoptosis-Inducing Ligand - antagonists & inhibitors TNF-Related Apoptosis-Inducing Ligand - metabolism Tumor necrosis factor Tumor Necrosis Factor Ligand Superfamily Member 14 - antagonists & inhibitors Tumor Necrosis Factor Ligand Superfamily Member 14 - metabolism Tumor Necrosis Factor Ligand Superfamily Member 15 - antagonists & inhibitors Tumor Necrosis Factor Ligand Superfamily Member 15 - metabolism Tumor Necrosis Factors - antagonists & inhibitors Tumor Necrosis Factors - immunology Tumor Necrosis Factors - metabolism
Title	Beyond TNF: TNF superfamily cytokines as targets for the treatment of rheumatic diseases
URI	https://link.springer.com/article/10.1038/nrrheum.2017.22 https://www.ncbi.nlm.nih.gov/pubmed/28275260 https://www.proquest.com/docview/1884214529 https://www.proquest.com/docview/1876499812 https://pubmed.ncbi.nlm.nih.gov/PMC5486401
Volume	13
WOSCitedRecordID	wos000397312400005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVPQU databaseName: Biological Science Database (ProQuest) customDbUrl: eissn: 1759-4804 dateEnd: 20171231 omitProxy: false ssIdentifier: ssj0064689 issn: 1759-4790 databaseCode: M7P dateStart: 20051101 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1759-4804 dateEnd: 20171231 omitProxy: false ssIdentifier: ssj0064689 issn: 1759-4790 databaseCode: 7X7 dateStart: 20090401 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1759-4804 dateEnd: 20171231 omitProxy: false ssIdentifier: ssj0064689 issn: 1759-4790 databaseCode: BENPR dateStart: 20090401 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7RFqFeeD8CZTESEnBIm9hJ7HBBBXXFhdUKFWlvUewkagVKtskuEv-eGccJzQq4cPHFE8X2jD0znvE3AK-CwOhCCOEXQsU-Icr5OhbcL6tKprrUpHVssQm5WKjVKl26C7fOpVUOZ6I9qIvG0B35SahURKjaPH2_vvKpahRFV10JjT04IJQEblP3lsNJnESJLYGHGjKlG6RggPYR6qRu24tyS0_RQ3nM-UQr7Z7N15TTbuLkTvTUKqX5nf-dzl247cxRdtrLzz24Udb34dZnF3B_AKv-hQs7X8zfUcO67bps-1sRZn5umm-UNs_yjvUp5R1DI5ihUcnGDHbWVMyuAmHDMhcQ6h7C1_nZ-cdPvivG4Bv0eTZ-LsLcKKFFoePY6FBXaNrIJDKJrqo0CHIdJblE86BIpBFFHGqTm0oFeWHCtOJGPIL9uqnLJ8BCYdCIKeNCo2-J_qNKFcpREHNUlBE2HhwPzMiMQyqnghnfMxsxFypz3MuIexnnHrwZP1j3IB1_J31B3M36V6bj9s5OI4WWYZoo5cFrS0EbHP-Ks-jfKeDYCSprQnk0ocSNaabdA-szdzB02W--e_By7KYvKdmtLpst0eC6ohsc4mgf9wI3Tgs9ZBmjD-qBnIjiSEBw4dOe-vLCwobHNLIg9ODtILTXhvXn1Xr67yk8g0Mi7BOZjmB_027L53DT_Nhcdu0M9uRK2lbN4ODD2WL5ZWb35y8F80HA
linkProvider	ProQuest
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VgigX3o9AoUYCUQ5pEzuJHSSEKmDVqu2KwyLtLcROolZF2SXZBfVP8RuZiZPQrIBbD1xy8TixnfE87JlvAF54ntGZEMLNhApdQpRzdSi4mxeFjHWuSes0xSbkeKym0_jTGvzscmEorLKTiY2gzmaGzsh3faUCQtXm8bv5N5eqRtHtaldCw7LFYX7-A122-u3BB_y_LzkffZy833fbqgKuQeN94abCT40SWmQ6DI32dYE6WkaBiXRRxJ6X6iBKJeq5LJJGZKGvTWoK5aWZ8eOCG4HvvQJXUY5LcvbktHfwoiBqSu6hRo7pxMrroISE2i2r6iRfUuq7L3c4H2jBVV1wQRmuBmqu3NY2SnB0639bvttwszW32Z7dH3dgLS_vwvXjNqDgHkxtBg-bjEdv6MHq5Tyv7KkPM-eL2RmlBbC0ZjZkvmZo5DM0mlkfoc9mBWtWnbBvWXvhVd-Hz5cyrwewXs7K_BEwXxg00vIw0-g7o3-sYoX7xAs5GgIBPhzY6X5-YlokdioI8jVpIgKESlpuSYhbEs4d2O47zC0Iyd9Jt4ibEptF24uvZC9QaPnGkVIOvGooSIDhV3EWNg8Dx05QYAPKzQElCh4zbO5YLWkFX5385jMHnvfN1JOC-cp8tiQaXFd0830c7UPL4P20uOIyRB_bATlg_Z6A4NCHLeXpSQOLHtLIPN-B190muTCsP6_W439PYQs29ifHR8nRwfjwCdygTjZoaxPWF9UyfwrXzPfFaV09a-QAgy-XvXN-AQ0knhA
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VLaq48H4ECjUSCDikm9h5OEgIFdoVVWG1QkXam4mdRK1AyZLsgvrX-HXM5EWzAm49cMnF48R2ZuYb2_MAeOI4RidCCDsR0rcpo5ytfcHtNMvCSKeaUKcuNhFOp3I-j2Yb8LOLhSG3yk4n1oo6KQydkY9dKT3Kqs2jcda6Rcz2J68X32yqIEU3rV05jYZFjtKzH7h9q14d7uO_fsr55OD47Tu7rTBgGzTkl3Ys3NhIoUWifd9oV2eI12HgmUBnWeQ4sfaCOETMS4LQiMR3tYlNJp04MW6UcSPwvZdgM0QjwxvB5puD6exjhwOBF9QF-BCfIzq_crrEQkKO87I8SVcUCO-Gu5wPMHEdGc5B47rb5trdbQ2Jk2v_82Jeh6utIc72Gsm5ARtpfhO2PrSuBrdg3sT2sOPp5CU9WLVapGVzHsTM2bL4QgEDLK5Y40xfMTT_GZrTrPfdZ0XG6j9AWXFZexVW3YZPFzKvOzDKizy9B8wVBs231E807qpx5ywjiRLk-BxNBA8fFux2jKBMm6OdSoV8VbWvgJCq5RxFnKM4t-B532HRpCf5O-kOcZZq4mt7xab2PIk2cRRIacGzmoJUG34VZ9FEaODYKUnYgHJ7QIkqyQybO7ZTrUqs1G-es-Bx30w9yc0vT4sV0eC6RhEanRbcbZi9nxaXPPRx921BOBCDnoASpQ9b8tOTOmG6TyNzXAtedAJzblh_Xq37_57CDmyhwKj3h9OjB3CF-jTeXNswWpar9CFcNt-Xp1X5qFUKDD5ftOj8Ak71qDA
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Beyond+TNF%3A+TNF+superfamily+cytokines+as+targets+for+the+treatment+of+rheumatic+diseases&rft.jtitle=Nature+reviews.+Rheumatology&rft.au=Croft%2C+Michael&rft.au=Siegel%2C+Richard+M&rft.date=2017-04-01&rft.pub=Nature+Publishing+Group&rft.issn=1759-4790&rft.volume=13&rft.issue=4&rft.spage=217&rft_id=info:doi/10.1038%2Fnrrheum.2017.22&rft.externalDocID=A486449688
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1759-4790&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1759-4790&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1759-4790&client=summon